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ABSTRACT




High-throughput mRNA sequencing (also known as RNA-Seq) promises to be
the technique of choice for studying transcriptome profiles, offering several advan-
tages over old techniques such as microarrays. This technique provides the ability to
develop precise methodologies for a variety of RNA-Seq applications including gene
expression quantification, novel transcript and exon discovery, differential expression
(DE) and splice variant detection. The detection of significantly changing features
(e.g. genes, transcript isoforms, exons) in expression across biological samples is a
primary application of RNA-Seq. Uncovering which features are significantly differ-
entially expressed between samples can provide insight into their functions.
One major limitation with the majority of recently developed methods for
RNA-Seq differential expression is the dependency on annotated biological features
to detect expression differences across samples. This forces the identification of ex-
pression levels and the detection of significant changes to known genomic regions.
Thus, any significant changes occurring in unannotated regions will not be captured.
To overcome this limitation, we developed a novel segmentation approach,
Island-Based (IBSeq), for analyzing differential expression in RNA-Seq and targeted
sequencing (exome capture) data without specific knowledge of an isoform. IBSeq
vii
segmentation determines individual islands of expression based on windowed read
counts that can be compared across experimental conditions to determine differential
island expression. In order to detect differentially expressed features, the significance
of DE islands corresponding to each feature are combined using combined p-value
methods. We evaluated the performance of our approach by comparing it to a number
of existing gene DE methods using several benchmark MAQC RNA-Seq datasets.
Using the area under ROC curve (auROC) as a performance metric, results show
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Over the past decade, next-generation sequencing (NGS) technologies have
developed rapidly, revolutionizing genome research and changing the landscape of
genetic studies. They have afforded researchers the ability to sequence known and
unknown mRNA transcripts that can be either coding or non-coding using RNA-Seq
and captureSeq methodologies. Using the captureSeq approach, Mercer et al. [104]
were able to expand by 12% the number of exonic structures that did not belong to
known models. This indicates the power of next-generation sequencing approaches
in providing novel information about the complexity of transcripts. Others have
used RNA-Seq to expand the knowledge of transcribed regions [57, 149], including
long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) [164, 165]. Perhaps
the most well-known of these studies was performed by the ENCODE Consortium
[37], which focused on understanding encoded elements within the human genome.
The GENCODE group relied heavily on RNA-Seq data to improve the accuracy of
protein-coding regions, pseudogenes, and noncoding regions in the human genome
[60, 65, 61].
The advent of RNA-Seq has enabled researchers and scientists to study the
transcriptome at an unprecedented rate and has lately become the standard technol-
ogy for transcriptome analysis. It is based on the direct sequencing of complemen-
tary DNA (cDNA) [109]. An RNA-Seq experiment starts with the extraction of total
RNA or a portion such as polyadenylated RNA [159]. The extracted RNA is then
1
converted to a library of double stranded cDNA and sheared into small fragments.
In the next step, adapters are attached to one or both sides of each cDNA fragment.
Using next-generation sequencing platforms, each cDNA fragment is sequenced and
a short sequence (read) from one end of the fragment (single-end tag) or from both
ends (paired-end tag) is obtained. The obtained reads are mapped to the reference
genome or transcriptome to measure the abundance of each transcript.
1.1 Motivation
With the massive and complex datasets generated by next-generation sequenc-
ing techniques, there has been a significant effort during the last few years to develop
computational methods to draw meaningful findings from this data. As a result of
this effort, several methods have been developed to model RNA-Seq data and detect
for differential expression across biological samples. The majority of these methods
are based on parametric assumptions where discrete probability distributions such as
binomial, Poisson and negative binomial are used. For differential expression analysis,
most RNA-Seq approaches follow a similar workflow (Figure 1.1) where mapped reads
are summarized according to known biological features such as exons, transcripts, or
genes which restricts the mapping of read sequences to existing annotations. Thus,
reads that map to regions outside annotated features will not be captured even in well
annotated genomes (e.g. human and mouse) [116] and consequently changes in those
regions will be missed. Additionally, previously undetected cassette-based isoforms
will be ignored and summarized accordingly to known isoform annotations. While us-
ing known annotations allows for insightful analysis of how gene expression changes
in differing conditions, it also is limiting in understanding how the gene structure
itself might also change.
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Figure 1.1: RNA-Seq workflow for differential expression analysis. Figure adapted
from [97].
To illustrate this problem, Pickrell et al. [121] found about 15% of mapped
reads were located outside annotated exons in their Nigerian HapMap samples. Alicia
et al. [116] showed an example of transcripts that fall outside annotated exons for
the RNA binding protein 39 gene in LNCaP prostate cancer cells. Our own work,
highlighted in Figure 1.2, shows an expression level for microarray data that shows dif-
ferential expression outside of a known rat gene. This differential transcription would
be ignored by current analysis methods, even though it has been experimentally deter-
mined that this region is part of the upstream gene. Looking at the annotated mouse
homology, it can be inferred that the 3’ UTR extends into this region, even if there
is no support from the current rat annotation. Further analysis of this differentially
expressed transcript shows an association with axonal localization [59].
Furthermore, when detecting for gene DE, most current gene DE methods
summarize read counts on the gene level. However, given the fact that most genes
consist of multiple exons and the distribution of read counts in exons for a single
gene can be different [158], this may provide inaccurate results. Thus, if genes are
broken down into smaller regions, such as exons or even smaller fragments, and DE
analysis is performed on those regions, the significance of the overall region can be
determined using combined p-values which may improve the accuracy of detecting
3
Figure 1.2: Illustration of regions missed by current annotations. The 3’ UTR region
has a significant change between samples T14 vs T0 and samples T7 vs T0. The
annotated mouse CaMK4 gene extends into this region. However, the corresponding
rat CaMK4 gene annotation terminates prior to the differentially expressed region,
which was subsequently verified to be part of the rat CaMK4 gene [59].
DE genes. Therefore, each region in the overall gene region will participate in the
computation of the overall gene significance based on its degree of importance which
ensures that regions in the gene are not treated equally.
1.2 Dissertation Contributions
In order to alleviate the issues resulting from dependence on annotations, a
novel Island-Based (IBSeq) approach is developed for RNA-Seq differential expression
analysis. In this approach (detailed in Chapter 5), the genome is split into small
fixed non-overlapping regions (windows). Those regions are then classified based
on their read count densities into high and low density regions. In the next step,
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adjacent regions with similar densities are merged together constructing larger regions
called islands. First, a per base count is computed for each sample using BEDTools
[125]. To construct regions, per-base read counts are summarized over a small fixed
window (10-50bp) to minimize small variance in coverage due to noise. Once regions
are constructed for the entire genome, regions are classified as high or low density
regions based on an average threshold calculated for each sample. For each sample,
high density islands are constructed by merging contiguous high density regions and
similarly for the low density islands. The constructed islands are then overlapped
and tested for differential expression (DE) across samples using Welch’s t-test (an
adaptation of Student’s t-test) or Wilcoxon test. Low density islands resulting from
the overlap are removed due to the lack of enough alignment to perform the DE test.
To detect which genetic features (e.g. genes) are differentially expressed be-
tween samples, the significance of DE islands that overlap with each feature is com-
bined using combined p-values methods (e.g. Fisher’s method). DE islands that
do not correspond to any feature are considered novel DE regions. Those regions
are annotated along with their closest features. To evaluate the performance of the
IBSeq approach, a comparison analysis is conducted to compare the approach with
a number of existing differential expression analysis methods using benchmark Mi-
croarray Quality Control (MAQC) RNA-Seq datasets. Using ROC curves and auROC
as performance metrics, results show that IBSeq outperforms all other methods as
illustrated by an increased auROC.
1.3 Dissertation Outline
The reminder of this dissertation is outlined as follows. Chapter 2 reviews the
basic concepts of molecular biology. It starts with a description of basic molecular
biology concepts such as cells, DNA, RNA, proteins, genes, and genomes. It also
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explains the Central Dogma of Molecular Biology and the process of protein synthe-
sis. This chapter also discusses the mechanism of alternative splicing and shows the
different types of alternative splicing events.
Chapter 3 gives a detailed overview of high-throughout next-generation se-
quencing technologies. It starts with reviewing first-generation sequencing techniques
including the Sanger and Maxam-Gilbert methods. Section 3.2 explains in detail the
next-generation sequencing techniques and gives a brief description of the widely
known sequencing platforms (e.g. Roche 454, Illumina, and SOLiD). It also provides
a brief description of NGS applications. Next-generation sequencing data format is
discussed in Section 3.4. The chapter ends with a brief review of genome assembly
and alignment and explains some of their algorithms.
Chapter 4 provides a detailed description of RNA-Seq Methodologies. It be-
gins with a brief review of the developmental milestones of transcriptome analysis
and discuss the different methods (e.g. Expressed Sequencing Tags, Serial Analysis
of Gene Expression, and Microarrays) applied in this realm. Section 4.3 deals in de-
tail with RNA-Seq methodologies. It discusses the RNA-Seq workflow and provides
detailed information about its applications such as transcript assembly, transcript
quantification, and differential expression. It also explains the current state-of-the-
art approaches for RNA-Seq analysis particularly in the area of differential expression
which is the main focus of this dissertation.
Chapter 5 describes IBSeq, an island-based approach for RNA-seq differential
expression analysis. This chapter discusses all aspects of the IBSeq approach. It
begins with a brief description of the current available methods for RNA-seq differ-
ential expression analysis and shows the limitations associated with them. Section
5.2 describes the IBSeq approach for performing differential expression using RNA-
Seq data and explains the design and implementation of the different steps in this
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approach. Section 5.3 reports the results of evaluating the performance of IBSeq by
comparing it with a number of current differential expression analysis methods using
publicly available benchmark RNA-Seq datasets. The chapter ends with a conclusion
presented in Section 5.4.
Chapter 6 presents a comparative study of different combined p-value methods
for gene differential expression using RNA-Seq data. Since IBSeq approach deter-
mines whether a feature (e.g. gene, exon) is significantly differentially expressed
or not between samples by combining the p-values of the regions corresponding to
that feature, this study is conducted in order to determine which combining p-values
method provides the best performance among the widely used methods. In this chap-
ter, six different combining p-value methods are compared using publicly available
RNA-Seq datasets. Section 6.2.1 describes the different combining methods consid-
ered in this study and Section 6.3 reports the results of this comparison. Section 6.4
concludes this chapter.





2.1 Organisms and Cells
Cells are the basic unit of all living organisms on earth. They are the compo-
nents that make any thing alive and control the structures and functions of any unit
in all organisms. The size of cells may vary, but typical cell size may range between 1
(bacteria) and 100 (plant) micrometers [14]. Human bodies are made up of trillions
of cells with at least 200 distinct cell types. Organisms can be classified based on
their cell type into two main categories:
1. Single-cell: organisms made up of only one cell, such as bacteria and yeast,
are called single-celled or uni-cellular organisms.
2. Multi-cellular: organisms that consist of more than one cell are known as
multicellular organisms.
Organisms are called prokaryotes if they lack a cell nucleus (the place where DNA
is contained and protected) or any membrane-encased organelles, otherwise they are
known as eukaryotes. Unicellular organisms may be prokaryotic or eukaryotic. How-
ever, most prokaryotes are single cell organisms. Both prokaryotes and eukaryotes
cells have a protection barrier composed of a phospholipids and proteins called a
plasma membrane used to enclose the cytoplasm and protect the cell from the out-
side environment. It regulates the movement of materials into and out of the cell.
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One of the most important organelles in the cell structure are the ribosomes which
provide the machinery for protein synthesis. Figure 2.1 shows an example of typical
animal, bacteria, and plant cells structures.
Figure 2.1: Typical animal, bacteria, and plant cells [156]. Used with permission.
In multicellular organisms, cells are organized in tissues (group of cells) which
perform a specific function, and several tissues are organized to form organs.
2.2 Nucleic Acids
In all living organisms, genetic information is stored in two types of nucleic
acid molecules called deoxyribonucleic acid (DNA) and ribonucleic acid(RNA). These
molecules are used to carry genetic information in the cell and transmit it from one
generation to the next [134]. DNA and RNA molecules are polymers consisting of
four units: Adenine (A), Cytosine (C), Guanine (G), and Thymine (T) [69]. For
RNA, Thymine (T) is replaced by Uracil (U). These units are called nucleotides (also
known as bases) and consist of three main parts: sugar, phosphate group, and one
of the two bases (a purine or a pyrimidine) as shown in Figure 2.2. Since DNA is
organized in a double-helix, the nucleotide bases form a complementary pair where
Adenine is complementary to Thymine (or Uracil in the case of RNA) and Guanine is
complementary to Cytosine. Figure 2.3 shows an example of double-stranded DNA.
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Figure 2.2: The chemical structure of nucleotides [124].
Figure 2.3: DNA double helix [123].
2.3 Proteins
The fundamental components of all living things are proteins [69]. Besides
water, proteins are the most common substance in the cell where they take up to
20% of a eukaryotic cell’s weight [14]. They do most of the work in the cell and make
the life of all organisms possible. Proteins consist of one or more long chains called
polypeptides. Each polypeptide is made up of 20 different small subunits called amino
acids, linked together by peptide bounds into a single-linear chain. All 20 amino acids
have the same basic structure consisting of an amino group (NH2), carboxyl group
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(COOH), and a side-chain (R) attached to a central alpha carbon (C). Figure 2.4
shows the basic structure of an amino acid and how amino acids are linked together
by peptide bounds.
Figure 2.4: The chemical structure of amino acids and how they are linked [2].
The linear sequence of amino acids that make up a protein is the first level
of protein structure also known as the primary structure. This linear amino acid
sequence is derived from the corresponding nucleotide sequence of the messenger
RNA in a process called translation (discussed in the next section) during protein
synthesis.
2.4 Central Dogma of Molecular Biology
In 1958, Francis Crick used the term “Central Dogma” to describe the phenom-
ena that biological information flow occurs in only one direction, from DNA to RNA
to proteins. The Central Dogma of Molecular Biology states that once sequential
information gets into proteins, it can not get out again. This shows the one way flow
which indicates that once genetic information has passed to proteins, it cannot flow
back to nucleic acids. In 1970, Crick restated the phenomenon of the Central Dogma
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of Molecular Biology and described the information flow in nine possible transforms
(Figure 2.5) classified into three groups:
1. General transfers: DNA→ DNA, DNA→ RNA, and RNA→ Protein. These
transfers have strong evidence that they occur in all cells [29].
2. Special transfers: RNA→ RNA, RNA→ DNA, and DNA→ Protein. These
transfers may occur under some specific conditions such as in a laboratory or
in the case of some viruses [29].
3. Unknown transfers: Protein → Protein, Protein → RNA, and Protein →
DNA. These transfers are very unlikely to occur [29].
Figure 2.5: The Central Dogma of Molecular Biology [29]. Solid arrows represent
the general transfers and dotted arrows show the special transfers. Unknown transfers
are shown in red.
The general transfers describe the flow of information from one form to another
in three primary biological processes, DNA replication, transcription, and translation
as shown in Figure 2.6.
1. Replication is a process by which a cell makes an exact copy of its DNA molecule
prior to a cell division. Thus, every time the cell divides, the double strands
of the DNA is separated into single-stranded regions by an enzyme called DNA
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Figure 2.6: The journey of genetic information from DNA to protein. Image adapted
from [152].
Helicase. Each strand will serve as a template to form a new strand of comple-
mentary DNA resulting in two identical copies of the DNA molecule, each will
consist of an old strand and a new complementary strand as shown in Figure
2.7. The formation of the new strands is performed by enzymes called DNA
Figure 2.7: The DNA replication [33]
polymerase where they bind to the old single strands and begin synthesizing the
new complementary strands. Figure 2.8 shows an example of DNA replication.
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Figure 2.8: Example of DNA replication
2. Transcription is the process by which genetic information is transferred from
a portion of DNA to an RNA molecule called messenger RNA (mRNA). This
process is performed by an enzyme called RNA Polymerase that binds to a
region on the DNA called a promoter (a DNA region allowing RNA polymerase
and transcription factors to bind to initiate the transcription of a particular
gene) and starts making a copy of a complementary RNA sequence known as
the primary transcript or precursor mRNA (pre-mRNA). The pre-mRNA is
made up of introns and exons as shown in Figure 2.9. Exons are then joined
Figure 2.9: Protein synthesis process [43]
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together and introns are cut out to form a molecule called mature mRNA (see
Figure 2.9) in a process known as RNA splicing. Some protein transcription
factors bind in or next to the promoter initiating transcription by facilitating
the unwinding of the double stranded DNA to allow RNA polymerase to read
only one single strand DNA and create mRNA molecule. The transcription
process is terminated when RNA polymerase reaches the termination sequence.
RNA polymerase then releases the mRNA and detaches from the DNA.
3. Translation is the process by which messenger RNA (mRNA) is translated into
a linear chain of amino acids that forms proteins (Figures 2.6 and 2.9). This
process is performed by ribosomes (very large complexes of RNA and proteins)
with the help of several types of transfer RNA molecules (tRNA), all within the
cytoplasm. In mRNA, each three non-overlapping bases called a codon map to
a particular amino acid. Since there are four bases, 64 different combinations
or codons (43 = 64) can be formed constructing a genetic codon table known
as the genetic code. Figure 2.10 shows an example of codons and the genetic
code.
Figure 2.10: The genetic code. (Left) series of codons in a part of messenger RNA
(mRNA) molecule [45]; (Right) The genetic codon table representing the genetic code.
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Most of the 20 amino acids are encoded by more than one codon which in
general differs only in the last nucleotide. Three of these codons (UAA, UAG,
and UGA) are used to end the synthesis of a protein sequence and do not
encode for any amino acid (stop codons). In contrast, one codon (AUG) is
used to start the translation process (start codon) and codes for the amino acid
methionine (Met), the first amino acid in the polypeptide chain. Thus, the
purpose of the translation process is to map a sequence of codons to a sequence
of amino acids. The process starts by transporting mature mRNA out of the
nucleus to the cytoplasm. The ribosome then binds to the mRNA at the start
codon. As mRNA passes through the ribosome, the ribosome starts matching
anticodon sequences carried by the tRNA to the mRNA codon sequence forming
a polypeptide chain. This process continues until the ribosome reaches a stop
codon which ends the synthesis of the polypeptide chain and releases it.
2.5 Genes and Genomes
In all organisms, genetic information is stored in one or more replicable double-
stranded DNA molecules called chromosomes (Figure 2.11). Each chromosome is
made up of two copies of DNA molecule linked together. They contain genes, reg-
ulatory elements and other nucleotide sequences. The DNA molecules are wrapped
around proteins called histones resulting in a structure known as chromatin (Figure
2.11). Whereas prokaryotic cells have a single chromosome, eukaryotic cells have one
or more chromosomes. In a single human cell, there are 23 pairs of linear chromo-
somes, for a total of 46 chromosomes. Twenty-two of these pairs, called autosomes,
are similar in both males and females. The 23rd pair is the sex-determination system
and is referred to as the X and Y chromosomes. Females have two X chromosomes
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Figure 2.11: The structure of chromosomes [24].
Genome refers to the complete set of genetic information in an organism [69].
A gene is DNA segment located on a chromosome that has all required information
to make a gene-product(s), which can be protein or RNA. They are the basic units of
inheritance. Each chromosome contains thousands of genes. It was estimated by the
Human Genome Project that humans have between 20,000 and 25,000 genes [68].
2.6 Gene Expression and Alternative Splicing
2.6.1 Gene Expression
Gene expression is a process by which gene regions on a chromosome are tran-
scribed to RNA and, in most cases, translated to proteins as discussed in section 2.4
and shown in Figure 2.9. Every gene is composed of a set of two segments called
exons and introns. While exon segments end up coding for proteins in the coding
sequence (expressed sequence), intron segments do not code for proteins and there-
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fore represent the non-coding sequence. As discussed in section 2.4, the transcription
process first generates the primary transcripts which contain both exons and introns.
Next, RNA binding proteins called splicing factors initiate the splicing process in
which introns are spliced out at spliceosomes (a snRNA and protein complex that is
used to remove introns from a transcribed pre-mRNA) and exons are linked together
and transported to the ribosome for translation to proteins.
While thousands of genes are present in cells, not all genes are expressed at
once. At any particular time, only a small fraction of these genes are expressed.
In general, genes are said to be on (expressed) if their molecular product can be
synthesized or off (not expressed) if they cannot be. Thus, it is the role of cells to
determine which genes to turn on and which genes to turn off during any time. This
process is called gene regulation. For instance, a brain cell turns on genes that encode
brain proteins, but a muscle cell will leave those genes off. The measurement of
gene expression is determined by looking at how much a particular gene is expressed
within a cell or tissue. One approximate measure of gene expression is the amount of
mRNA produced by various genes in the cell. RNA gene expression analysis is useful
for cell function and differentiation studies that estimate which and when genes are
expressed and how much their expression changes across biological conditions. There
are several techniques for RNA gene expression analysis including Serial Analysis of
Gene Expression (SAGE), microarrays, and lately high-throughput mRNA sequencing
(RNA-Seq).
2.6.2 Alternative Splicing
Alternative splicing is the process by which pre-mRNA exons of a gene are
rejoined together in multiple ways producing different mRNA variants known as iso-
forms or splice variants during the RNA Splicing process. In the human genome for
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instance, current estimates suggest that more than 90% of the genes have multiple
protein isoforms [76]. The process of alternative splicing is shown in Figure 2.12.
Figure 2.12: Alternative splicing. One gene can produce multiple proteins [54].
When the primary transcript enters the spliceosome, the spliceosome recognizes
the sequence of exon-intron boundaries at regions known as the splice donor site GU
(in the 5’ direction) and splice acceptor site AG ( in the 3’ direction). Since those
two sequences are not sufficient for the spliceosome to recognize the existence of an
intron, another sequence called the branch site located 20-50 bases upstream of the
acceptor site is used. The splicesome also recognizes a region upstream 5’ from the
AG sequence and located about 5-40 bases before the 3’ end of the intron being spliced
known as polypyrimidine tract. This region is rich in pyrimidine nucleotides (C and
U). Figure 2.13 shows the regions involved in the splicing process.
The mechanism of splicing process shown in Figure 2.14 uses five small nuclear
ribonucleic-protein complexes (snRNAs) known as U1, U2, U4, U5, U6. It begins
when U1 binds to the splice site end at the 5’ direction making the branch site bind
to the G nucleotide at the donor site to form a phosphodiester linkage [19]. Then, U2
binds to the branch site sequence (denoted by A in Figure 2.14). In the next step, U4,
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Figure 2.13: Sequences involved in the RNA splicing. (Pu=A or G; Py=C or U)
[128].
U5, and U6 complex binds to the 5’ splice site replacing the position of U1. U1 and
U4 are then displaced and U6 binds to U2 at the 5’ splice site and near the branch
site. In the final step, U5 binds to the exon sequences and the intron is removed.
Figure 2.14: Alternative splicing mechanism [36].
There are several types of alternative splicing events, some of which may occur
at the 5’ or 3’ untranslated regions (UTRs), others may occur at the coding regions.
Figure 2.15 shows an overview of possible alternative splicing events.
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Figure 2.15: Alternative splicing events [11].
• Exon Cassette (Exon skipping): in this type, one or more exons are included
or excluded from the final processed mRNA product. It is the most common
gene splicing in mammals. However, this type is extremely rare in prokaryotes.
• Alternative 5’ splice sites: in this type, two or more splice sites are recog-
nized at the 3’ end of an exon. The donor site (alternative 5’ splice junction) is
used, changing the 3’ boundary of the upstream exon. This type may account
for about 18.4% of alternative splicing events in eukaryotes [76].
• Alternative 3’ splice sites: like the alternative 5’ splice sites, alternative 3’
splice sites occurs when two or more splice sites are recognized at the 5’ end of
an exon. The acceptor site (alternative 3’ splice junction) is used, changing the
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5’ boundary of the downstream exon. This type may account for about 7.9% of
alternative splicing events in eukaryotes [76].
• Intron retention: this type simply occurs when an intron remains in the final
mRNA transcript.
• Mutually exclusive exons: this type occurs when multiple cassette exons are
used in a mutually exclusive manner. Namely, one of two exons remains in the
mature mRNA but not both.
• Alternative promoter: this type usually occurs when two promoters are
available. A different promoter is used to generate different splice variants.
The exons of 5’ terminal of the processed mRNA can be switched to generate
alternative isoforms. The specific transcription factors of the cell determine
which promoter to use.
• Alternative polyadenylation sites (Poly A): similarly to alternative pro-
moter, this type occurs when 3’UTR exons of the processed mRNA are alter-
natively spliced producing alternative polyadenylation sites [19].
In addition to the above discussed events, there are other exon-related events
that may occur as well. These events are discussed below and shown in Figure 2.16.
Figure 2.16: Alternative exon events [19].
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• Exon extension: this event may occur when one or more exons are extended
by adding an additional sequence to a transcript producing a slightly modified
mRNA sequence.
• Exon truncation: this event may occur when a partial (not fully) of a cassette
exon is added to a mRNA sequence. This is usually done by removing either
3’or 5’ (sometimes both) producing different translated protein [19].
• Exon retention: this type of alternative splicing events may occur when ad-
ditional exons located in an intronic region are included in the final mRNA




3.1 First-Generation Sequencing Methods
Until 2004, the dominant technique for DNA sequencing was the one intro-
duced by Frederick Sanger in 1977 that bears his name. The Sanger method, also
known as dideoxy sequencing or chain termination, uses modified nucleotides called
dideoxynucleotides (ddNTPs) with the normal nucleotides (NTPs). Essentially, the
structure of dideoxynucleotides is the same as normal nucleotides except they con-
tain a hydrogen group on the 3 carbon instead of a hydroxyl group (OH) which act
as chain terminators. In this method, DNA samples are divided into four separate
sequencing reactions, each containing the single-stranded DNA to be sequenced, the
four normal deoxynucleotides (dATP, dGTP, dCTP and dTTP), DNA polymerase,
DNA primer, and one of the four radioactively or fluorescently labelled dideoxynu-
cleotides (ddATP, ddGTP, ddCTP and ddTTP). Since the dideoxynucleotides lack
the 3’-OH group required to form a phosphodiester bond between two nucleotides,
once dideoxynucleotides are incorporated, the process is halted, stopping any further
formation resulting in a collection of DNA fragments with different lengths. Each
fragment is terminated by the same dideoxynucleotide in each of the four reactions.
This collection of DNA fragments is then heat denatured and run on a gel elec-
trophoresis to separate fragments by size. Each reaction is run on one of four lanes
(A, T, G, and C), each with a different ddNTP. Thus, the lane containing the ddATP
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for instance will have only those fragments that terminate at an adenosine (A) and
the same for ddGTP which will have only fragments that all stop at guanine (G)
and so on. When all lane contents have been read across the gel, DNA bands are
visualized by exposing the gel to a UV light or X-ray film and the DNA sequence is
then read from the film. Figure 3.1 illustrates the workflow of Sanger method.
Figure 3.1: The workflow of Sanger sequencing method [73].
Another first-generation sequencing method was introduced by Maxam and
Gilbert in 1977 known as a chemical cleavage method. This method is based on
chemical modification of DNA and subsequent cleavage at specific bases. Like the
Sanger method, the DNA template is split into four reactions, G, A + G, C, and
C + T . In each reaction, the DNA fragment is radioactively labeled at the 5’ end
and chemically cleaved at one of the four nucleotides. Thus, purines (A+G) might
be depurinated by formic acid whereas pyrimidines (C+T) are methylated using
hydrazine. By using hot piperidine, the DNA fragments are then cut into a series
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of labeled fragments. In order to separate fragments by size, the fragments in the
four reactions are arranged side by side in a gel electrophoresis. In the next step,
fragments are visualized by exposing the gel to X-ray film for autoradiography which
generates a series of dark bands each corresponding to a radio labelled DNA fragment
[34]. Figure 3.2 describes the Maxam-Gilbert workflow.
Figure 3.2: Maxam-Gilbert method for DNA sequencing [103]
Although this method was accurate and more popular, it did not take hold as
the preferable sequencing technique due to the complexity and the extensive use of
toxic chemicals.
Since the automated Sanger method can only accurately sequence up to 1000bp,
researchers had to think of other methods that can sequence longer sequences. As a
result, a new method called shotgun sequencing (also known as shotgun cloning) was
developed. In this method, the DNA segment of interest is cut into smaller fragments
using restriction enzymes or mechanical shearing. Each fragment is sequenced indi-
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vidually and the sequences of these fragments are then reassembled based on sequence
overlaps into continuous sequence resulting in a complete DNA sequence (Figure 3.3).
The shotgun sequencing method was used to sequence the entire human genome by
the Human Genome Project (HGP).
Figure 3.3: (a) Description of Shotgun sequencing method. (b) To reduce the com-
plexity of normal shotgun sequencing resulting from the large sequences, a hierarchical
approach is used [26]. The genome is broken down into a set of large equal segments
with known order (clone-based methods) which are then sequenced using the normal
shotgun sequencing.
3.2 Next-Generation Sequencing Technologies
Due to the limitations associated with first-generation sequencing technologies
such as the inability to sequence large genomes in a reasonable time with an optimal
cost, there was a great demand to develop new techniques. As a result, new, fast,
inexpensive, and more accurate techniques known as Next-Generation Sequencing
(NGS) were introduced in 2004. Unlike the old sequencing techniques, which are
based on chain termination methodologies, the new techniques are based on parallel
sequencing. Thus, they are also known as Massively Parallel Sequencing Techniques.
NGS technologies share similar protocols to perform the sequencing process classified
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into three main steps, (1) template preparation, (2) sequencing and imaging, and (3)
data analysis [105]. Each technique has its own protocols to perform each step and
each generates a different type of data in the form of short sequences called reads.
With their ability to generate tens of millions of short sequences in a relatively
short time with a low cost, NGS technologies has expanded the frontiers of genomic
and transcriptomic research opening new avenues for genetic investigations. However,
they require long run times spanning from 8 hours to 10 days based on the platform
and the read type (single-end or paird-end) [99]. Several NGS platforms are commer-
cially available including Roche/454 GS FLX, Illumina/Solexa, Applied Biosystems
SOLiD (ABI) analyzer, Polonator G.007, Helicos/HeliScope, Pacific BioSciences/RS,
and IonTorrent. Each platform generates a different read length ranging from 35-
1000bp within a different run time and each has a different throughput. Table 3.1
shows a detailed description of each sequencing platform while Table 3.2 describes
the key applications used by each platform.
The first three platforms, Roche 454, Illumina, and SOLiD described in Table
3.1 are the most widely used sequencers dominating the sequencing market. He-
licos/Heliscope, and PacBio/RS are refereed to as next-next generation sequencing
platforms (or third-generation sequencing). In the next sections, a brief description
of each sequencing platform is given.
3.2.1 Roche/454 GS FLX Sequencer
The Roche 454 was introduced to the market in 2004 as the first next-generation
sequencing machine and is currently developed by 454 Life Sciences Corporation. The
sequencing technology of Roche 454 is based on the sequencing-by-synthesis technique
known as pyrosequencing [168]. This machine uses an emulsion PCR amplification
technique to make copies of the DNA templates [30] in which every DNA fragment is
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Roche/GS FLX+ emPCR Up to 1,000 700 Mb Pyrosequencing
Illumina/HiSeq
2500
Bridge-PCR 2x100 600 Gb Sequencing by
synthesis
ABI/SOLiD 5500xl emPCR 50-100bp >100 Gb Sequencing by
ligation
Polonator/G.007 emPCR 26 8-10 Gbp Sequencing by
ligation
Helicos/Heliscope No 25-55 21-35 Gb Single
Molecule
sequencing
PacBio RS No 1,000-10,000 13 Gb Single
Molecule
Real Time
IonTorrent/Proton No 100-200 10 Gb Semiconductor
sequencing
bound to a single bead. Each bead is isolated in oil micelles which contain emulsion
PCR reactants producing about one million copies of each DNA fragment [168, 30].
During the pyrosequencing process, four different nucleotides are flowed on a solid
surface containing a number of wells designed to hold the beads (each well can be
used to hold one bead), producing light from a reaction utilizing pyrophosphate gen-
erated when nucleotide incorporation occurs [30]. This process continues for a number
of cycles and the light for each incorporation is recorded for each bead [30]. Thus,
the intensity of the light recorded for a particular well indicates the number of in-
corporated nucleotides [169]. Initially, the Roche 454 Sequencer had a read length
of 100-150 bp, but the more recent, Roche GS FLX Titanium XL+ can produce an
average read length up to 1000 bp.
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3.2.2 Illumina/Solexa Genome Analyzer
The Illumina/Solexa Genome Analyzer is the most widely used sequencer
which was introduced to the market as the second NGS machine. Initially, the plat-
form was introduced by Solexa in 2006 which was later renamed as the Illumina
Genome Analyzer (GA) [30]. The sequencing technology of Illumina is based on a
sequencing-by-synthesis technique. Unlike Roche 454 which uses emulsion-PCR for
DNA template amplification, Illumina GA uses a technique called solid-phase ampli-
fication[105]. In this technique, all four nucleotides are added simultaneously along
with the DNA polymerase into oligo-primed cluster fragments in flow cell channels
[168] (8-channel sealed glass microfabricated device) which allows bridge amplification
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of those fragments producing multiple DNA copies (or clusters) [99] for sequencing.
As a result, a reverse complimentary copy of the template DNA is generated. The gen-
erated clusters are then imaged and the incorporation of the next cycle of nucleotides
are begun after chemically removing the 3’ blocked groups and the flurophores of the
next incorporation [30]. In the last step, the generated images are analyzed resulting
in a separate sequence for each cluster. Given the fact that a high percentage of
published papers use short read sequences produced by Illumina technology, Illumina
platforms are considered to be the most widely used sequencers. At present, the Il-
lumina HiSeq 2500 can produce 2 x 100 bp (pair-end reads) and has a throughput of
600 Gbp/run (see Table 3.1 for more details).
3.2.3 Applied Biosystems SOLiD Sequencer
The ABI SOLiD (Sequencing by Oligo Ligation and Detection) sequencer
was developed by Life Technologies and purchased by Applied Biosystems which
introduced it to the market in October 2006. The sequencing technology of ABI
SOLiD is based on a sequencing-by-ligation approach using emulsion-PCR with small
magnetic beads to amplify DNA fragments for sequencing [99, 168]. This technique
is similar to the one for Roche 454 except that SOLiD beads are much smaller than
Roche beads (1µm versus 28 µm) [30]. The SOLiD sequencer uses DNA ligase and
two-base-encoded probes to amplify fragments [105]. In this system, two slides are
used per run, each of which can be divided into four or eight data points. Thus, two
adjacent bases represents a single data point and each base is interrogated twice [30].
Four dyes are utilized by the two-base encoded probes to encode for 16 possible two
base combinations as shown in Figure 3.4.
The SOLiD instrument generates a different type of data known as colorspace
data based on the concept of the 2-base encoding technique explained above. Thus,
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Figure 3.4: Possible dinucleotides encoded by each color [99]
instead of using the normal nucleotide bases A, C, G, and T, SOLiD makes use of
the four colors shown in Figure 3.4. Since there are four bases, the four colors are
represented as 0, 1, 2, and 3 (blue=0, green=1, yellow=2, red=3) and the final se-
quence file contains only these numbers. In 2011, Applied Biosystems has introduced
the updated platform SOLiD 5500xl with its ability to generate up to 100 Gbp per
run with a read length of 50-100 bp.
3.2.4 Polonator G.007
Polonator G.007 is a new platform introduced to the market by Dover Systems
in collaboration with the Church Laboratory of Harvard Medical School. The plat-
form is based on the polony sequencing technology and uses a sequencing-by-ligation
technique using randomly arrayed, bead-based, emulsion-PCR for DNA amplification
[168]. The machine tends to be cheaper than other NGS machines and inexpensive




The Helicos Heliscope was introduced in 2008 as the first single molecular se-
quencing technology which means that fluorescent nucleotides are added singly. It
is classified as the third-generation sequencing or next-next generation sequencing
platform developed by Helicos BioSciences Corporation. This platform has two char-
acteristics that do not exist with the next-generation sequencing platforms discussed
earlier. First, since this platform has the ability to sequence a single DNA molecule,
there is no need to perform any PCR amplification before sequencing which classi-
fies the platform as single-molecule real time (SMRT) [168]. This makes the Helicos
Heliscope free from any errors and biases that may occur at the amplification stage
which simplifies, eases, and speeds up the process of DNA preparation. Second, the
signal generated from hybridizing a particular nucleotide is recorded during the real
reaction time making this platform more capable of monitoring it [96]. The average
read length of this sequencer is 25-55bp. Although this platform has the advantages
of being free from DNA preparation errors, sensitivity can be a big issue [30].
3.2.6 Pacific BioSciences RS
The PacBio RS platform was developed by Pacific BioSciences Corporation and
introduced to the market in 2010 as one of the third-generation sequencing technolo-
gies. Like Helicos Heliscope, this platform uses single molecule real time sequencing
technology (SMRT) and does not require any PCR amplification before sequencing.
This platform performs and analyzes biochemical reactions at the individual molecule
level where nucleotides are added singly. This sequencer has several advantages in-
cluding high speed performance, fast sample preparation (from 4-6 hours instead of




Ion Torrent introduced its first sequencer (PGM) at the end of 2010. This
sequencer was developed by Life Technologies and uses semiconductor sequencing
technology. This technique works on the concept that when a nucleotide is incor-
porated into the DNA by a polymerase, a hydrogen ion (H+) is released. The Ion
Torrent sequencer can recognize the incorporation of a nucleotide by detecting and
measuring the change in pH [96]. In 2012, Ion Torrent introduced its second gen-
eration sequencing platform, The Proton. This sequencer is considered as the first
sequencing machine that does not require a fluorescent probe or any scanning materi-
als which make this sequencer fast, cheap, and small in size. The average read length
of the Ion Torrent Proton is 100-200 bp and the throughput is up to 10 Gb per run.
3.3 Applications of Next-Generation Sequencing Technologies
The introduction of NGS technologies has made it possible for variety of ge-
nomic research areas to utilize the low cost and large amount of data generated by
them. To date, these technologies have been comprehensively applied in a variety of
realms such as whole-genome sequencing, targeted resequencing, Small RNA sequenc-
ing, Epigenetics, and Metagenomics. Table 3.3 describes the common applications of
next-generation sequencing technologies in genomic research.
3.4 Next-Generation Sequencing Data
Raw sequence data from next-generation sequencing platforms discussed earlier
are stored in an NIH’s archive known as the Sequence Read Archive (SRA). It is
the primary archive of high-throughput sequencing data where short read sequences
are stored and made available to the research community. This has the advantage
of reproducing analyses and allowing for new discoveries. The SRA database has
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Table 3.3: Applications of NGS technologies [141, 169].
Category Examples of Applications
De novo genome sequencing Initial generation of large eukaryotic genomes.
Whole-genome sequencing Comprehensive polymorphisms and mutation
discovery.
Targeted genomic resequencing Discovery of mutations or polymorphisms.
Transcriptome sequencing Gene expression and quantification, alterna-
tive splicing, transcript annotation, discovery of
transcribed SNPs or somatic mutations.
Small RNA sequencing MircoRNA profiling.
Epigenetics Transcription factor with its direct targets, his-
tone modification profiling, DNA methylation.
Chromatin immunoprecipitation
sequencing (ChIP-Seq)
Genome wide mapping of protein-DNA
interactions.
Metagenomics Environmental genomics.
Personal genomes Possible usage in personalized medicine.
grown sharply since its first release. Figure 3.5 represents SRA database growth. In
addition to the raw NGS data, SRA now stores alignment information in the form of
read placements on a reference sequence. In this section, a detailed description of the
raw sequence data and alignment data is presented.
3.4.1 Raw Data (Short Reads) Format
Almost all next-generation sequencing platforms report short read sequences in
either Fasta [94, 119] or Fastq [25] format. However, Fastq has become quickly the
standard format for storing short read sequences. In this section, a brief description
of the two common data formats is given.
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Figure 3.5: SRA database growth. Figure taken from the NCBI website [145]
3.4.1.1 FASTA Format
FASTA format is a text-based format consisting of a single-line description
followed by multiple lines of sequence data. It is the simplest and earliest standard
format supported by early sequence search algorithms such as FASTA [94, 119] and
BLAST [1]. Each sequence in this format starts with an indicator “>” used to
distinguish the description line from the sequence data line. The word after the
indicator “>” is used as a sequence identifier and separated from the description by
a space. Figure 3.6 shows an example of this format.
Since FASTA format does not support quality values, quality values (when they
are required) are often reported in separate files as with the Roche 454 sequencer.
3.4.1.2 FASTQ Format
FASTQ format is another text-based format used to store short read sequences.
It has become the standard format for storing data from next generation sequencing
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Figure 3.6: Example of FASTA format.
platforms allowing the storage of both sequence and quality scores of each read. Each
sequence in FASTQ format consists of four lines. The first line begins with the symbol
@ indicating the beginning of a read sequence followed by a sequence identifier and
(optionally) a description. This line is used to identify the sequence and distinguishing
it from other sequences. The second line contains the actual sequence letters (bases).
The third line begins with the symbol ”+” and optionally followed by the same
sequence identifier. It is not required to have anything after the symbol ”+” but if
present, it must be the sequence identifier. The fourth line contains the quality scores
encoded for the sequence. This line should have the same length as the second line
indicating a quality score value for each base in the sequence. Figure 3.7 shows an
example of FASTQ format.
Quality score values (also known as a Phred or Q score) in FASTQ format
are integer values representing the probability P that the corresponding base call is
incorrect. They are generated based on a quality table (See Table 3.4) that uses
a number of quality predictor values. The scores are encoded by adding 33 to the
Phred score for Sanger and 64 for Illumina and then converted to an ASCII format.
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Figure 3.7: Example of FASTQ format.
However, Illumina has a different scale for quality scores using an offset of 64 instead
of 33. In order to compute the quality scores, two different equations have been in
use. The first one is the standard Sanger assessment approach (Phred+33) which
uses the following equation:
Q = −10 log10 P (P = 10
−Q
10 )
Thus, if a base were assigned a Phred quality score of 30, the probability this base
were called incorrectly is 1 in 1000 (see Table 3.4 for more examples) which means
that the accuracy of calling this base is 99.9%. A Phred score of 20 (99% chance
a base was called correctly) or above is considered a good score cutoff for inclusion
of next generation sequence data. The Illumina has a slightly different method of
calculating quality scores using the odds P/(1− P ) instead of the probability P .
Q = −10 log10
P
1− P
For storing raw data sequences, Illumina uses FASTQ format whereas Roche
454 uses SFF (Sequence Flowgram Format) format, a binary file containing sequence
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Table 3.4: Quality scores and base calling accuracy.
Phred Quality Score Probability of Incorrect Call Call Accuracy
10 1 in 10 90%
20 1 in 100 99%
30 1 in 1000 99.9%
40 1 in 10000 99.99%
50 1 in 100000 99.999%
identifiers, sequences letters, base call quality values and other meta information all
together in one file. The nucleotide sequences and quality scores in SFF files can
be extracted into two files (using Roche sffinfo), a sequence file in FASTA format
(ends with .fna) and a quality file (ends with .qual). SOLiD produces data in color
space and the primary output is generated in two separate files, a reads file in csfasta
format (ends with .csfasta) and quality scores in a quality file (ends with .qual).
3.4.2 Sequence Alignment Format
Two sequence alignment data formats are typically used for NGS applications,
(1) Sequence Alignment/Map format (SAM) [89] and (2) Binary Alignment/Map
(BAM), the compressed binary version of SAM format. SAM format has become
the standard format for storing alignment data which is often converted into BAM
format to allow more efficient storage.
3.4.2.1 Sequence Alignment/Map (SAM) Format
SAM format is a tab-delimited text format consists of two sections, an optional
header section and an alignment section. All header section lines begin with the
symbol ”@”, used to distinguish header lines from alignment lines, followed by two-
letter record type code. Each line in the alignment section consists of 11 mandatory
fields representing one alignment hit. Figure 3.8 shows an example of a SAM file.
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Figure 3.8: Example of a SAM file.
Each data field in the header has an explicit field tag represented by two ASCII
characters. For example, the VN tag describes the File format version, SN represents
the sequence name, and ID represents unique read group identifier (a complete list
of those field tags can be found in SAM format specification [136]). The alignment
section consists of multiple lines, each having 11 mandatory fields (see Table 3.5)
representing one alignment hit. The fields must appear in the same order shown in
Table 3.5. The FLAG field in the alignment section is a bitwise flag. The meaning of
each bit is shown in Table 3.6.
SAM format has been accepted as the standard format for storing alignment
data by all alignment methods including those used by next-generation sequencing.
3.5 Genome Assembly and Alignment
The raw data generated by NGS machines are in the form of millions of short
sequences (reads). Prior to performing any analysis on this data and as a first step in
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Table 3.5: Alignment section fields in SAM format. Field 12 represents the optional
fields.
Col. Field Description
1 QNAME Query NAME (Query pair NAME if paired)
2 FLAG Bitwise FLAG
3 RNAME Reference sequence name
4 POS 1-based leftmost mapping POSition/coordinate of clipped sequence
5 MAPQ MAPping quality (Phred-scaled)
6 CIGAR Extended CIGAR string
7 MRNM Mate reference sequence NaMe (“=” if the same as <RNAME>)
8 MPOS 1-based leftmost Mate POSition
9 ISIZE Inferred insert SIZE
10 SEQ Query SEQuence on the same strand as the reference
11 QUAL Query QUALity (ASCII-33 gives the Phred base quality)
12 OPT Variable OPTional fields in the format TAG:VTYPE:VALUE
Table 3.6: The FLAG field in SAM format.
Flag Decimal Value Description
0X0001 1 The read is paired in sequencing
0X0002 2 The read is mapped in a proper pair
0X0004 4 The query sequence itself is unmapped
0X0008 8 The mate is unmapped
0X0010 16 Strand of the query (1 for reverse strand)
0X0020 32 Strand of the mate
0X0040 64 The read is the first read in a pair
0X0080 128 The read is the second read in a pair
0X0100 256 The alignment is nor primary
0X0200 512 The read fails platform/vendor quality checks
0X0400 1024 The read is either a PCR or an optical duplicate
any analysis, short read sequences need to be mapped back to a reference genome in
order to determine the locations from which they originate. This process, referred to
as a reference-based assembly, is performed assuming a reference genome is available.
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It is the preferable approach since it is fast, easy, and capable of determining the
locations of original sequence.
In cases where an organism does not have a reference genome, read sequences
can be de novo assembled in order to construct the original reference sequence. Since
read sequences are very short and large in number, this approach is more complicated
and difficult than the previous one.
3.5.1 Alignment
Alignment is the process of mapping a DNA sequence to its reference sequence
of origin to determine the most probable source location in the genome reference. It
usually reports the most likely sequence of origin either as an identical sequence (100%
match) or similar sequence (allowing a number of mismatch bases in the sequence
alignment) [72]. Figure 3.9 shows the principle of sequence alignment (for illustration
purposes, reads are represented by only 4bp length).
Figure 3.9: The concept of sequence alignment [72].
Several alignment algorithms have been developed in the last few years in-
cluding the traditional alignment algorithms BLAST [1] and BLAT [75]. The main
purpose of the BLAST and BLAT algorithms is to align DNA/protein sequences to
a library or database of sequences to find shared sequence homology. The BLAST
and BLAT tools tend to be efficient at aligning a small number of longer sequences.
However, for large amounts of short reads, BLAST and BLAT can be very slow and
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computationally expensive which make them impractical for mapping millions of short
reads to a reference genome. Consequently, there was a critical need to develop new
algorithms and tools to map NGS data in a fast and efficient manner. As a result, a
number of short read alignment approaches have been developed, most of which are
based on two approaches (explained below): (1) Hash-Based approach (also known
as Spaced-Seed Indexing) and (2) Burrows Wheeler Transform (BWT) approach.
3.5.1.1 Hash-Based Approach
Most of the initially designed alignment algorithms are based on a hash-table
approach [41]. The idea behind this method is to use a mapping function to map iden-
tified values called keys to their associated values through a special index. Alignment
algorithms have implemented this type of data structure to first index the sequences
and then associate them with read identifiers as shown in Figure 3.10.
Figure 3.10: The hash-based approach [41].
In this approach, the hash table is constructed using either the sequences reads
or the reference genome. If the table is constructed using the sequence reads, then
the reference genome is used to search the table and vise versa for the second case.
Examples of tools using this approach are shown in Table 3.7.
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Table 3.7: Examples of hash-based aligners [41].
Tool Hash-Table Construction Technique
MAQ [85] Based on read sequences
ELAND (Illumina) Based on read sequences
SOAP [84] Based on reference genome
MOSAIK [63] Based on reference genome
SHRiMP [135] Based on read sequences
ZOOM [93] Based on read sequences
BFAST [64] Based on reference genome
The hash table in this approach is usually implemented as spaced seeds in
which a read sequence is divided into four equal-sized subsequences called “seeds”.
The idea behind this is that if a read, as a whole, can be perfectly mapped to the
genome sequence, then all its seeds will mapped perfectly as well. On the other hand,
if there were a one mismatch of mapping the entire read, this one base difference
should fall within one of the seeds [155]. By using this technique to align the six
possible pairs of the seeds to the genome reference, one can be sure all read hits with
two mismatch are reported [41, 155] . Figure 3.11a shows the spaced seed indexing
methodology.
3.5.1.2 Burrows-Wheeler Transform (BWT) Approach
The Burrows-Wheeler transform (also known as Block-Sorting) is a technique
introduced by Michael Burrows and David Wheeler in 1994 for data compression. The
idea of this approach is based on character rotations and sorting. The transformation
of the input string is performed by rotating all string characters after appending a
special character to the end of the string. This character should be smaller than all
alphabets in the string. In the next step, resulted rotations are sorted in lexicograph-
ical order and the last column is taken as the output string, bwt(s). Figure 3.12
44
Figure 3.11: Genome alignment techniques [41]. (a) Spaced seed indexing method.
Reference sequence positions are divided into equal-sized segments called “seeds”. Seeds
are then paired and stored in a look-up table. Each read sequence is also divided into 4
segments and the seed pairs are used as keys to search for the matching positions in the
reference sequence [155]. (b) Bowtie implementation of Burrows-Wheeler transform.
Reads are aligned base by base from right to left and all active locations are reported.
If no match position where the read might map is found, Bowtie backs up and make
substitution.
shows an example of this process. For the human genome, this method can be used
the same as in the example above. Figure 3.13 shows an example of creating a BWT
of 14-mer genomic sequence.
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Figure 3.12: Burrows-Wheeler transform process. The Burrows-Wheeler matrix T
is constructed as a matrix whose rows represent all possible rotations of T. The prop-
erty of reversible permutation of BWT(T) allows the original text to be reconstructed.
Note that the output string has many repeated characters which make it more easy to
compress.
Figure 3.13: Burrows-Wheeler transform for genomic sequence data [41].
Examples of tools using this approach include BOWTIE [79], BWA [86], and
SOAP2 [87]. These tools implement BWT technique using Ferragina-Manzini index
(FM-index) [39] data structure to align read sequences to the reference sequence. As
a fact, algorithms implementing BWT are much faster than hash-based algorithms.
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Since Bowtie is considered the most widely used algorithm for aligning NGS
data, a brief description of the tool is given below.
3.5.1.3 Bowtie
Bowtie [79], as defined by its developers, is an ultrafast, memory-efficient short
read aligner that align short DNA sequences (reads) to large genomes. The implemen-
tation of Bowtie is based on a Burrows-Wheeler transform indexing schema shown
in Figures 3.12 and 3.13. It uses an FM-index to build genome indices. Using this
transform, the entire human genome can be compressed and indexed into about 2.2
gigabytes (Bowtie 1) of memory (3.2 gigabytes for Bowtie2). Bowtie has the ability
to align 25 million of reads with length 35bp to the human reference genome in an ap-
proximately one CPU hour utilizing about 1.3 gigabytes of memory [79]. In order to
find the exact match hits, Bowtie uses BWT with the Ferragina-Manzini (FM) exact-
matching algorithm. Since this algorithm does not allow for mismatches and favors
high quality reads, Bowtie has extended it by introducing a novel approach to the FM
algorithm called a quality-aware backtracking [79]. To limit excessive backtracking,
Bowtie has introduced another extension called double indexing [79].
Bowtie uses BWT to align reads base by base to the transformed reference
genome starting from the end of the read (right to left) as shown in Figure 3.11b.
When a read is traversed, all matched locations to which the read might align are
reported. If no matched location is found in which the read might perfectly map,
Bowtie backtracks to the previous base and incorporates a base and restarts the search
[155]. Using this technique, Bowtie has proved to be one of the fastest alignment
algorithms (faster than the hash-based algorithm of MAQ by 30-fold [41]).
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3.5.2 Assembly
As discussed earlier, the reference-based assembly approach is the preferable
choice if the reference genome exists. However, in cases where the reference genome
is not available (de novo sequencing), the short DNA sequences (reads) must be
assembled to computationally reconstruct the original DNA sequence. In general,
assembly refers to the process of grouping short reads into contigs and contigs into
scaffolds (Figure 3.14), without using any prior knowledge of the genome. Contigs
and consensus sequences are built from multiple sequence alignment (overlapping
between reads) of short reads with no gaps. Scaffolds (or supercontigs) refers to an
ordered and oriented set of contigs separated by gaps. These gaps might be identified
by one or more ”N” where the consecutive number of N’s determines the gap length
[107]. The process of constructing scaffolds from contigs is called scaffolding.
Figure 3.14: Overview of genome assembly [51].
Several graph-based assembly algorithms have been developed for NGS data
which are classified into three main categories, (1) Greedy graph assembly, (2) Over-
lap/layout/consensus (OLC), and (3) De Brujin graphs (DBG) algorithms [107]. In
order to discuss and understand these approaches, a brief review of graph theory
concept should be given.
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3.5.2.1 Graphs and Graph Theory
A graph is a data structure representation composed of a set of nodes (vertices)
and a set of edges (arcs) between them. It is defined as G = (V, E) where V is the
set of nodes (vertices) and E is the set of edges (arcs). Each edge in the graph is
connected by a pair of nodes u and v and u,v ∈ V. A graph is called a directed (or
digraph) graph if the edges have a direction associated with them and undirected if
the edges have no direction. The directed edge that points to a node at the end
of the edge (sink node) is called the incoming edge for that node. Similarly, if the
node is the source node of the directed edge, the edge is called outgoing edge for that
node. The number of edges incident to a node v represents the degree of the node
and defined as deg(v). A sequence of directed edges e1, e2, ..., en such that each node
is adjacent to the next form a path P defined as P = ((v1,v2),(v2,v3),.....,(vk, vk+1)).
Thus, the number of edges in a graph path represents its length. A graph is called
connected if each pair of nodes can be joined by a path and disconnected otherwise.
If a path starts and ends with the same node, it is called a graph cycle. A cyclic
graph is defined as a graph containing at least one cycle whereas acyclic graph is a
graph that does not contain any cycle. A directed and acyclic graph is referred to as
a directed acyclic graph (DAG).
The sequences of short reads can be represented as an overlap graph where
nodes represent reads and edges represent the overlaps between reads [107]. Since
edges represent the overlaps, each path in the graph will represent a contig. This can
be performed using a k-mer graph (for a de Brujin graph) such that nodes represent
all equal-sized subsequences (k-mers) and edges represents the overlaps between the
subsequences by k-1 bases (Figure 3.15b). Alternatively, nodes can be used to implic-
itly represent the overlap between the subsequences by k-1 bases and edges represent
the subsequences [107] as shown in Figure 3.15c.
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Figure 3.15: A k-mer graph representation of a read sequence with k=4 [107]. The
path in the figure represents consensus sequence. The overlaps are computed by per-
forming a pairwise alignment between all reads
3.5.2.2 Greedy Graph Assembly
Among the simplest types of assembly algorithms is the greedy graph assembly.
In this approach, individual short reads are grouped together into contigs starting
with one read (or contig) and continually adding more overlapping reads (or contigs)
that have the best overlap until no more reads/contigs can be added [107, 122]. It is
a prefix-to-suffix overlap which means the prefix of one read overlaps with a sufficient
number of bases with suffix of another read. The best overlap in this context refers
to the reads with the highest overlap score determined by the number of matched
bases in the overlap. Examples of algorithms using greedy assembly strategy include
SSAKE [161], SHARCGS [35], and VCAKE [71].
3.5.2.3 Overlap/Layout/Consensus (OLC)
Th OLC approach uses the concept of an overlap graph in three steps, (1)
overlap, (2) layout, and (3) consensus.
1. Overlap: in this step, pairwise overlaps between read sequences are discovered
by comparing the reads to each other. This comparison is performed using a
heuristic seed and extend approach to find a set of k-mers across all reads and
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determine which reads share the k-mers. The set of k-mers will be then used
as a seed for the alignment between reads [107].
2. Layout: in the layout step, the overlap graph, discussed in step (1), is con-
structed so that an approximate layout of the read sequences can be given.
This graph is then analyzed to define the paths corresponding to fragments
in the genome being assembled. The final aim of this analysis is to define a
single path that includes all nodes such that a node is visited only one time.
This path will correspond to the reconstruction of the genome using all read
sequences [122].
3. Consensus: in the final step, consensus sequence is constructed using multiple
sequence alignment (MSA).
The OLC approach often used for assemblies designed based on the old Sanger
sequences. Examples of OLC algorithms are the Celera assembler [112], Arachne [8],
and CAP3 [67].
3.5.2.4 De Bruijn Graph (DBG)
De Bruijn graph assembly (or the Eulerian approach) is the most widely
adopted approach to assemble NGS short reads generated by Illumina and SOLiD. It
is also based on the concept of k-mer graphs discussed earlier. Generally, De Bruijn
graph is constructed as follows. To start, all reads are broken down into k-mers (sub-
sequences of length k) in which each node in the graph represent a k-mer of length
k-1 prefixes and suffixes of the original k-mer. Two nodes are connected by a directed
edge if (k-1)-suffix of the source node is a (k-1)-prefix of the sink node resulting in
an overlap of k-2 as shown in Figure 3.16.
The assembly problem in this context is equivalent to finding a path that
includes all edges in the graph [122]. This path, by which the program Euler assembler
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Figure 3.16: Example of de Bruijn graph assembly with k=4. The edges are labeled
with k-mers and nodes contain k-1 of the original k-mer.
[120] was known, is called a Eulerian path. It is a path in the graph traversing each
edge exactly once.
A number of assembly algorithms have been designed based on this approach
targeting specifically short read sequence data. Examples of these are Euler-SR [20,





Transcriptome refers to the set of all transcripts and their abundance in the cell
[159]. Generally, the term refers to the set of all RNA (mRNA, tRNA, rRNA, and non-
coding RNA) transcripts in a particular cell. By studying transcriptomics, different
genome-level functions can be identified, such as estimating when and where each
gene is expressed in the cell/tissue at a given time, detecting the amount of mRNAs
(RNA expression levels) in a particular cell (expression profiling), and discovering new
genes. Thus, one important goal of analyzing the whole transcriptome is to define and
catalogue the characteristics of all transcripts expressed in a particular cell (or tissue)
for a specific developmental stage [27]. Different techniques have been developed over
time for transcriptome analysis, starting with Northern blot analysis developed in
1977 leading to whole transcriptome sequencing with NGS in 2006. Figure 4.1 shows
the developmental milestones of transcriptome analysis.
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Figure 4.1: The developmental milestones of transcriptome analysis.
4.2 Transcriptome Analysis Techniques
4.2.1 Candidate Gene Approaches
4.2.1.1 Northern Blot
Northern blot was the first technique developed for transcriptome analysis by
James Alwine, David Kemp, and George Stark in 1977 to detect specific RNA (or
isolated mRNA) sequences for gene expression studies. The Northern blot procedure
starts with the extraction of mRNA from tissue samples or cells which is then purified.
The extracted mRNA is then size-separated by gel electrophoresis and separated RNA
samples are transferred to a nylon membrane. The RNA is detected in the final step
using an isotopic or non-isotopic labeled cDNA or RNA probe (Figure 4.2). The
throughput of this technique is quite low (detection of a few known transcripts) while
large amounts of input RNA is required [108].
4.2.1.2 Reverse Transcription Quantitative PCR (RT-qPCR)
Reverse transcription quantitative PCR (RT-qPCR) (also known as quantita-
tive real-time PCR or qRT-PCR) is one of the most popular techniques for accurately
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Figure 4.2: The Northern-blot procedure. [115].
measuring the mRNA level for a gene or locus proposed in 1989. It is used today
as means of validating RNA expression for a limited number of transcripts. This
technique requires the RNA to be converted into a more stable form called com-
plementary DNA (cDNA) using an enzyme called reverse transcriptase. Then PCR
amplification and probe hybridization is performed for the DNA molecule of interest.
To quantify the amount of mRNA template in the sample, the probe needs to be flu-
orescently labeled and the emission of this fluorescent label is recorded at each PCR
amplification step, allowing for a very accurate measurement of the original RNA. An
important step before performing any sample-to-sample comparison is to normalize
the output data generated from the RT-qPCR experiment. This technique has the
advantage of increasing the throughput and reducing the required amount of input
mRNA. However, RT-qPCR is not able to perform transcriptome-wide analysis, with
a throughput ranging on the order of hundreds of transcripts at a time [108].
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4.2.2 Sequencing-Based Approaches
4.2.2.1 Expressed Sequencing Tags (ESTs)
Expressed sequence tags (ESTs) are short DNA sequences (200 to 800 bases)
generated by sequencing the complementary DNA (cDNA) and used to determine
if a gene is expressed in a cell at a particular time. This process is performed by
sequencing 200-500 nucleotides from one or both ends of each cDNA creating 5’ESTs
and 3’ESTs (Figure 4.3). ESTs are then used to search genome databases (e.g.
GenBank, EMBL, and DDBJ) to find a matching sequence. Since ESTs are sequenced
from the transcribed regions, ESTs have been mainly used for discovering novel genes
and coding regions.
Figure 4.3: Overview of EST construction [9].
Since ESTs are a quick and inexpensive to construct, for a long time, this
method was the core method for gene transcript discovery. However, ESTs can be
error-prone, and do not typically cover the entirety of each transcript.
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4.2.2.2 Serial Analysis of Gene Expression (SAGE)
The SAGE method, developed by Dr. Victor Velculescu in 1995, was the first
tagged sequencing technique used for gene expression profiling. It was introduced as
an alternative method to microarrays for the detection of differentially expressed genes
by comparative analyses. This method was originally used for the investigation of
differentially expressed genes in colon cancer. Thus, a large number of SAGE studies
were focusing on cancer research. The general procedure of a SAGE experiment starts
with the isolation of mRNA from the input sample. From each mRNA fragment, a
small sequence (9-10 base pairs) called a SAGE tag is sequenced. These tags can be
serially analzyed and linked together to form a long chain. To identify the abundance
of each transcript, the number of times each a SAGE tag appears (called SAGE tag
number) is recorded. Figure 4.4 shows an overview of SAGE method.
Figure 4.4: Overview of SAGE method [138].
57
Although SAGE can be superior to microarrays since it that does not require
any prior knowledge of isolated genes and it produces digital counts of transcript
abundance, the method had not been used as widely as microarrays [108].
4.2.2.3 Massively Parallel Signature Sequencing (MPSS)
MPSS was introduced by Sydney Brenner in 2000 for conducting in-depth
expression profiling. It can be used to analyze the expression level of all genes in
a sample by counting the number of individual mRNA molecules produced by each
gene [127]. Similar to SAGE and unlike microarrays, MPSS does not require any prior
knowledge of identified genes before performing an experiment. It generates digital
data by counting all mRNA molecules in a sample. This process is performed through
the generation of a 17-20 nucleotides signature sequence from each mRNA at a specific
site upstream from its poly(A) tail [127]. This sequence is called a “signature” which
is used to identify the mRNA molecule. Thus, measuring the expression level of any
gene means counting the number of “signatures” for a gene’s mRNA.
4.2.3 Microarray Technology
Despite its limitations, microarray technology is the most widely used tech-
nique for transcriptome analysis [109]. It has dominated gene expression studies for
the last 15 years. Microarray technology is a hybridization-based technique that al-
lows simultaneously the analysis of hundreds of samples and measures the expression
levels of tens of thousands of known genes. The microarray itself is made of a collec-
tion of microscopic DNA spots attached to a solid surface (usually glass or silicon).
Each DNA spot on the array contains picomoles of a specific single-stranded DNA se-
quence or oligonucleotide called a probe. A single microarray chip can have hundreds
of thousands of spots, each can contain millions of genomic DNA or short stretch of
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oligo-nucleotide strands that correspond to a particular gene. Microarrays are used in
several studies including detecting and measuring gene expression (the most popular
use where the expression of a set of genes in one condition (e.g. diseased) is compared
to the same set of genes in another condition (e.g. healthy)), microarray mutation
analysis (mainly for SNP detection), and comparative genomic hybridization, which
is used to assess genome content in different cells or closely related organisms.
There are two types of microarrays: (1) Spotted arrays (spotting the DNA
onto the surface) and (2) In-situ synthesised oligonucleotide arrays where oligos are
built up base-by-base on the surface. The DNA microarray can be classified in their
structures into three types: (I) Single channel arrays (Affymetrix gene chips), (II)
Multiple channel (dual color (cDNA) microarrays), and (III) Specialty approaches
(Bead arrays such as Lynx, Illumina).
The general procedure of a microarray experiment, described in Figure 4.5,
starts by extracting RNA molecules from the cell/tissue of interest. The extracted
RNA molecules are then reverse-transcribed into cDNA using an enzyme called re-
verse transcriptase. The produced cDNAs are labeled with different fluorescent dyes,
typically Cy3 and Cy5 (e.g. red for condition A and green for condition B) using
a two-channel approach (i.e. Illumina) or biotin for single channel microarrays (i.e.
Affymetrix). Once the cDNAs of the sample have been labeled, they are allowed to
hybridize onto the the same glass slide. Performing this step will cause the cDNA
sequence to hybridize to specific spots on the glass slide containing its complementary
sequence. To remove any extra hybridization solution (unbound probe), a washing
step is performed to make sure only the labeled target of interest is the actual one.
Following hybridization, the spots are excited by a laser and scanned at appropriate
wavelengths to detect the different dyes [50]. The detected fluorescence is stored as
an image in a file (usually in tagged image format (.tiff)) for further analysis. The
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Figure 4.5: Microarray technology [81].
colors in the image represent the status of the gene in both conditions. Thus, when
a gene is expressed abundantly in the condition of interest (e.g. diseased) but not in
the control condition (e.g. healthy), the spot would appear as a red. In contrast, if a
gene was expressed at a higher level in the control, the spot would appear as a green.
In cases where a gene was expressed in both conditions, the spot would appear as a
yellow and as a black if it was not. The produced image in the last step is processed
and background and feature pixels are transformed into intensity values to quantify
the spots. Intensity values are combined into unique quantitative measures reflecting
the expression level of the gene deposited in a specific spot. In order to perform a
comparative analysis, signal intensities need to be normalized. Once miroarray data is
normalized, various differential expression analysis methods can be applied to detect
differentially expressed genes across conditions.
Despite its power of measuring the expression of thousands of genes, microarray
technology suffers from a number of limitations including:
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1. The technology requires the use of prior knowledge of the organism which make
it unable to detect novel transcripts.
2. The dynamic range of intensity levels is limited by the resolution of the scanner
used (typically 16-bits).
3. Since the data representing the expression level is derived from the hybridization
intensity, this data is noisy. [108].
4. There exists a likelihood of a cross-hybridization between mRNA sequences and
non-specific targets.
4.3 High-Throughput mRNA Sequencing (RNA-Seq)
The introduction of high-throughput sequencing technologies has revolution-
ized genome research in many areas including their applications to transcriptome pro-
filing studies. RNA-Seq (or Whole Transcriptome Shotgun Sequencing) refers to the
use of deep sequencing technologies for transcriptom analysis. The advent of RNA-Seq
has enabled researchers and scientists to study the transcriptome at an unprecedented
rate and has lately become the standard technology for transcriptomics. It is based on
the direct sequencing of complementary DNA (cDNA) using next-generation sequenc-
ing technologies [109]. RNA-Seq is proving to be the technique of choice for studying
transcriptome profiles offering several advantages over hybridization-based approaches
such as microarrays (Table 4.1), by providing the ability to detect known and novel
transcripts and to precisely measure transcript expression levels independent from
any prior knowledge of the genome sequence. Unlike microarrays, which generate
expression signal intensities, RNA-Seq generates quantitative expression read counts.
Thus, increasing read counts provides higher dynamic ranges at higher resolution,
which improves both sensitivity and quantitative accuracy. In addition, RNA-Seq
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makes it possible to access some transcriptome structures such as allele-specific ex-
pression, novel promoters, isoforms [116], alternative spliced variants, and sequence
variation (e.g. SNPs). RNA-Seq short reads (35-150 bases) provide information about
how two exons are connected, whereas long reads are useful for determining how mul-
tiple exons are connected [159]. Unlike microarrays, RNA-Seq has a low background
noise with high resolution. While microarrays offer resolution at the probe length,
RNA-Seq allows for a single base resolution. Such granularity allows for better de-
tection of splice variants. Furthermore, the ability to distinguish different isoforms
and different allelic expression is limited in microarrays but is high in RNA-Seq [159].
Also, the dynamic range for quantifying expression differences is limited to a few
hundred folds in microarrays, but can be nearly 10,000 fold with RNA-Seq data. One
key limitation for microarrays is the dependency on a reference genome. Although
RNA-Seq can take advantage of such an annotation, it also offers the ability for de
novo transcriptomics.
Table 4.1: Advantages of RNA-Seq over microarray technology.
Application RNA-Seq Microarray
Data Type Quantitative read counts Relative intensities
Technology High-throughput sequencing Hybridization
Resolution Single base From several to 100bp
Genome references Required in some cases Required
Dynamic range ∼10000-fold Few hundred-fold
Background noise Low High
RNA amount required Low High
Alternative splicing/novel
isoforms
Able to detect limited
Discover new genes Yes No
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4.3.1 RNA-Seq Workflow
The workflow of an RNA-Seq experiment is straightforward and generally starts
with the extraction of total RNA or a polyadenylated RNA.The extracted RNAs or
Poly(A) is then converted to a library of double stranded cDNA and sheared into
small fragments. In the next step, adapters are attached to one or both sides of each
cDNA fragment. Using next-generation sequencing platforms, each cDNA fragment
is sequenced and a short sequence (read) from one end of the fragment (single-end
tag) or from the two ends (paired-end tag) is obtained. Figure 4.6 shows the typical
RNA-Seq workflow. The obtained reads are then mapped to the reference genome
Figure 4.6: Workflow of RNA-Seq experiment.
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to measure the abundance of transcripts. If the reference genome was not available,
read sequences can be de novo assembled to construct the full set of transcripts and
estimate their abundance.
4.3.2 RNA-Seq Applications
RNA-Seq methodology has been applied to a variety of applications including
(I) transcriptome reconstruction, (II) transcript quantification, and (III) detection of
significant changes in the transcript expression levels across biological conditions. In
this section, a brief overview of each application is given.
4.3.2.1 Transcript Assembly
Transcriptome assembly, the foundation of transcriptome studies [101], is the
process of identifying the complete set of transcripts in the transcriptome. To perform
this task, RNA-Seq read sequences generated by NGS platforms need to be assembled
prior any further analysis. Three main methods were identified for transcriptome
assembly, (I) reference-based assembly (or ab initio), (II) de novo assembly, and (III)
combined assembly.
Reference-Based Assembly
Reconstructing the transcriptome in this method is built upon the available
reference genome, where read sequences in the first step are aligned directly to the
reference genome (Figure 4.7a) to determine their original locations using one of the
alignment tools mentioned in section 3.5. In the second step, a graph representing
all possible transcripts is built from the overlap between all reads (Figure 4.7b).
Transcripts are constructed in the final step by traversing the graph and defining
paths that, as a result, should correspond to transcripts. (Figure 4.7c) [101].
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Figure 2 | Overview of the reference-based transcriptome assembly strategy. The steps of the reference-based 
transcriptome strategy are shown using an example of a maize gene (GRMZM2G060216). a | Reads (grey) are first 
splice-aligned to a reference genome. b | A connectivity or splice graph is then constructed to represent all possible 
isoforms at a locus. c,d | Finally, alternative paths through the graph (blue, red, yellow and green) are followed to join 
compatible reads together into isoforms.
Applications. Reference-based transcriptome assembly 
is easier to perform for the simple transcriptomes of bac-
terial, archaeal and lower eukaryotic organisms, as these 
organisms have few introns and little alternative splicing. 
Transcription boundaries can be inferred from regions 
of contiguous read coverage in the genome even with-
out graph construction and traversal37,51,52. Alternative 
transcription start and stop sites can also be inferred 
based on the 5′ cap or poly(A) signals (if cap- or end-
specific experimental protocols are used)51,53. However, 
complications arise owing to the gene-dense nature of 
these genomes. Many genes overlap, resulting in adja-
cent genes being assembled into one transcript, even 
though they are not from a polycistronic RNA. Strand-
specific RNA-seq has successfully been used to separate 
adjacent overlapping genes from opposite strands in the 
genome51,52. Overlapping genes that are transcribed from 
the same strand and that also have comparable expres-
sion levels cannot easily be separated without using 
cap- or end-specific RNA-seq.
Plant and mammalian transcriptomes have complex 
alternative splicing patterns and are difficult to assemble 
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Figure 4.7: Overview of reference-based assembly method [101].
A variety of assembly lg rithms have been developed using reference-based
assembly including G-Mo.R-Se (Gene Modeling u i g RNA-Seq) [31], Cufflinks
[154], and Scripture [55]. Whereas G-Mo.R-Se builds a de ovo gene model based
on an exon identification approach, Cufflinks and Scripture use the concept of a
graph to assemble transcripts by using spliced reads (reads spanning exon-exon junc-
tions). In order to construct transcripts, both Cufflinks and Scripture apply similar
approaches to construct the graph, but differ in the traversing strategy. While Cuf-
flinks constructs an overlap graph based on the spliced alignment locations of the
reads, Scripture makes use of individual bases and all possible connections between
them (graph topology) to construct the graph.
There are a number of advantages associated with reference-based assembly
including its efficiency and sensitivity. Efficiency because assembly can be run on a
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small RNAs using parallel computing and sensitivity because of the ability to assemble
low abundance transcripts [101]. However, this method suffers from a few drawbacks.
For example, the reference genome quality may have a big impact on the assembly
process. Namely, if the reference genome contains a large number of mis-assemblies or
deletions, the assembly process will result in a mis-assembled transcriptome. Another
drawback is the errors resulting from the alignment process which will be carried over
to the assembly process as well. Last, since this method requires an organism reference
sequence, the method cannot be applied to organisms without a reference genome.
As an alternative, one may use a closely related species but the limitation with this
is that the assembly process will not be perfect and some transcripts from divergent
regions will be missed.
De novo Transcript Assembly
De novo assembly is a genome-independent method that does not require any
predefined reference genome. Thus, instead of mapping reads to the reference genome,
reads are directly used, based on their overlap, to construct transcripts. Assembly al-
gorithms such as Trans-ABySS [130], Rnnotator [102], Multiple-k [150], Trinity
[49], and Oases [137] assemble transcripts based on the construction of a De Bruijn
graph (discussed in section 3.5.2) but they differ slightly in the strategy for traversing
the graph. Once the De Bruijn graph is built, paths are traversed and false branch
points are trimmed resulting in paths that represent transcripts (Figure 4.8). The
advantage of this method is that it does not require a reference genome which means
it can be applied to organisms without a reference genome. Since it does use a ref-
erence sequence, this method is free from errors that may result from the alignment
process. In addition, the de novo assembly approach can be applied even with the
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Figure 3 | Overview of the de novo transcriptome assembly strategy. 
a | All substrings of length k (k-mers) are generated from each read. 
b | Each unique k-mer is used to represent a node (or vertex) in the 
De Bruijn graph, and pairs of nodes are connected if shifting a k-mer by 
one character creates an exact k–1 overlap between the two k-mers. 
Note that for non-strand-specific RNA sequencing data sets, the reverse 
complement of each k-mer will also be represented in the graph. Here, a 
simple example using 5-mers is shown. The example illustrates a SNP or 
sequencing error (for example, A/T) and an example of an intron or a 
deletion. Single-nucleotide differences cause ‘bubbles’ of length k in the 
De Brujin graph, whereas introns or deletions introduce a shorter path in 
the graph. c,d | Chains of adjacent nodes in the graph are collapsed into 
a single node when the first node has an out degree of one and the 
second node has an in degree of one. Last, as in the reference-based 
approach, four alternative paths (blue, red, yellow and green) through the 
graph are chosen. e | The isoforms are then assembled.
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Figure 4.8: Overview of de novo transcript assembly [101]. (a) K-mers of length
k=5 are generated from each read. (b) A de Bruijn graph is constructed where nodes
represent k-mers and edges represent overlaps between them. (c) The de Bruijn is
collapsed by merging adjacent nodes into a single node. (d) The graph is traversed and
paths are defined where each path corresponds to a separate isoform. (e) Isoforms are
then assembled.
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regions in the genome assembly. However, as with any computational method, the
de novo assembly has a few drawbacks. First, it is difficult to distinguish between
sequence variations and sequencing errors which make it nontrivial to determine the
trade-off between sensitivity and complexity [44]. Second, sequencing errors increase
the complexity of the graph by producing branch points. Last, determining the k seed
length can be an issue which may affect the assembly process. For instance, a smaller
value of k will result in a large number of overlaps and therefore more complex graph
and vise versa. Thus, choosing k in most cases will depend on the coverage. For
example, a small value of k is preferable when the coverage is low since it increases
the number of overlapping nodes to the graph.
The Combined Method
This method as it says from its name combines the two previous methods,
reference-based assembly and de novo transcript assembly taking the advantages of
both methods. Two main strategies are possible for this method, align-then-assemble
or assemble-then-align as shown in Figure 4.9.
In the align-then-assemble approach, RNA-Seq reads are first aligned to the
reference genome accounting for possible splicing events. Then transcripts are recon-
structed from the spliced alignments. In the assemble-then-align approach in contrast,
first transcripts are assembled directly from the RNA-Seq reads and splice-aligned to
the genome to define exon and intron structure and variation between alternative
spliced transcripts [56].
4.3.2.2 Transcript Quantification
Another application of RNA-Seq is the estimation of transcripts expression
levels (relative mRNA quantities) at the gene and isoform levels. It is performed in
68
Figure 4 | Alternative approaches for combined transcriptome assembly. The left choice depicts the align-then-
assemble strategy, in which reference-based assembly is followed by de novo assembly of reads that failed to align to 
the genome. The right choice depicts the assemble-then-align strategy, in which the reads are first de novo assembled 
and then scaffolded and extended using a reference genome. RNA sequencing (RNA-seq) reads are shown in red, and 
assembled transcripts are shown in orange.
Trans-spliced genes
Genes whose transcripts  
are created by the splicing 
together of two precursor 
mRNAs to form a single  
mature mRNA.
accurately from short reads. Cufflinks20 and Scripture16 
have been developed for efficiently reconstructing tran-
scripts from mammalian-sized data sets. A recent study 
showed that Cufflinks had a higher sensitivity and speci-
ficity than Scripture when detecting previously anno-
tated introns18. A comprehensive comparison of the 
performance of these programs is needed, however, as 
discussed in a later section. Also, it is not known how well 
these programs perform on polyploid plant transcrip-
tomes, in which different alleles from each subgenome 
need to be resolved.
Disadvantages. There are a few drawbacks to the 
reference-based strategy. The success of reference-based 
assemblers depends on the quality of the reference 
genome being used. Many genome assemblies, except 
those of a few model organisms, contain hundreds to 
thousands of misassemblies and large genomic dele-
tions54, which may lead to misassembled or partially 
assembled transcriptomes. Errors introduced by short-
read aligners are also carried over into the assembled 
transcripts. Spliced reads that span large introns can be 
missed because aligners often only search for introns that 
are smaller than a fixed length to reduce the required 
computational power. Also, aligners must successfully 
deal with reads that align equally well to multiple places 
in the genome. If these ‘multi-reads’ are excluded alto-
gether, then this will leave gaps in the reference-based 
assembly in regions that cannot be mapped uniquely. But 
if these reads are included by random assignment, then 
they could lead to the formation of transcripts from a 
region of the genome that has no transcription.
Reference-based transcriptome assembly is, of course, 
not possible without a reference genome. However, 
in some cases, it is possible to use the reference from 
a closely related species. The strawberry reference 
genome, for example, was used to assemble the raspberry 
transcriptome (J. Ward and C. Weber, Cornell Univ., 
personal communication); however, in these appli-
cations, transcripts from divergent genomic regions 
would be missed. Last, reference-based approaches 
cannot easily assemble trans-spliced genes55. Detection 
of trans-spliced genes has been shown to be crucial for 
understanding the genetic pathways involved in some 
cancers56, such as prostate cancer57.
In summary, reference-based assembly is generally 
preferable for cases in which a high-quality reference 
genome already exists. From our experience, these 
methods are very accurate and sensitive, as they can 
assemble full-length transcripts at a sequencing depth 
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Figure 4.9: The combine method for tra scriptome assembly. (Left) The align-
then-assemble approach (e.g. Cufflinks and Scripture). (Right) The assemble-then-
align approach (e.g. Trans-ABySS, Trini y, Oa es, and others) [101].
two steps, (1) aligning RNA-Seq reads to t e refer nc g nome and (2) m asuring
the abundances of ge s and isoforms based on the read lignments generated in (1).
Different methods have been developed for transcript quantification which can be
categorized into two strategies, count-based ethods and isoform-expression methods.
In count-based methods, ll transcripts are assu ed to have a single isoform
and reads are mapped uniquely to t e transcr pts (which is no always th case). In
its simplest form, count-based methods estimate isoform expression levels by count-
ing the number of uniquely mapped reads to a single isoform. Although this strategy
may work for some cases, it cannot be applied for genes with multiple isoforms. Thus,
the count-based method is appropriate for single isoform genes such as bacteria in
which alternative splicing does not occur [118]. However, due to alternative splicing
events in eukaryotic species where most genes have multiple isoforms, reads may map
to multiple isoforms resulting in an uncertainty of assigning reads to transcripts and
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estimate their expression levels. Because of its estimation bias and incorrect estima-
tion for alternative spliced genes [90], this method has a little use in the transcript
quantification realm and as result more complex methods have been developed to
handle those limitations.
The isoform-expression (or multi-read) methods have been developed to ad-
dress the issue of reads that map ambiguously to multiple isoforms and genes. Sev-
eral algorithms have implemented techniques such as generative models of RNA-Seq
reads, Poisson models, quadratic programming, and expectation-maximization (EM)
algorithms to estimate expression at both gene and isoform levels. Examples of these
are Cufflinks[154], ERANGE [109], RSEM [90], MISO [74], IsoEM [114], and rQuant
[12]. Most of these algorithms use a likelihood function to estimate isoform relative
abundances. Maximum likelihood estimate (MLE) is the term used to describe the
process of maximizing the likelihood function to infer isoform and gene expression
levels. All transcript quantification algorithms need to normalize read counts prior
to the quantification process in order to have accurate estimation results.
In their ERANGE package, Mortazavi et al. have proposed a multiread rescue
method by initially estimating gene abundances from normalized counts of unique
reads and use them to assign multireads to the most probable locations and re-
estimate the abundances based on the counts generated after the assignment. The
ERANGE reports transcript abundances in RPKM (Reads Per Kilobase of transcript
per Million mapped reads) (See Section 4.3.2.4 for more details about RPKM). Cuf-
flinks uses fractions of mapped reads to gene exons to estimate the relative expression
after normalizing for gene length. It uses fragment counts instead of read counts to
measure the abundance of transcripts by using FPKM (Fragment Per Kilobase of
exon per Million fragments mapped). To estimate the relative abundance of tran-
scripts, Cufflinks uses a generative statistical model of RNA-Seq to derive the likeli-
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hood for the abundances of a set of transcripts using a set of fragments. This model
is used in cases where fragments map to multiple transcripts by allowing probabilistic
deconvolution of RNA-Seq fragments densities [154].
Mixture-of-isoforms (MISO), a probabilistic framework, uses Bayesian infer-
ence to compute the probability that a read originated from a particular isoform. To
measure the abundance of a set of isoforms, MISO treats isoforms as a variable and
estimates a distribution over the values of this variable. The estimation process is per-
formed based on sampling where a set of techniques called Markov Chain Monte Carlo
(MCMC) is used. A more detailed description of the MISO framework can be found
in [74]. RSEM and IsoEM use similar models based on the well-known expectation-
maximization technique. RSEM does not require a reference genome, but it uses a set
of reference transcript sequences instead. These transcripts will be preprocessed and
used as a reference to which RNA-Seq reads will be aligned in order to estimate the
expression levels of transcripts and their credibility intervals (CI). RSEM estimates
maximum likelihood (ML) expression levels using expectation-maximization (EM)
algorithm. In addition to the computation of ML, RSEM computes 95% credibility
intervals and posterior mean estimate (PME) to measure the expression levels of each
gene and isoform [90] (refer to [90] for more details about RSEM).
IsoEM is a novel expectation-maximization (EM) algorithm for isoform fre-
quency estimation proposed by Nicolae et al. [114]. It takes the advantage of the
information provided by the distribution of insert sizes generated during the process
of library preparation. The E-step in IsoEM computes the expected number of reads
n(j) coming from isoform j with the assumption that isoform frequencies f(j) is cor-
rect based on weights wr,j (refer to [114] for how these weights are computed). In
the M-step, for each isoform j, a new value of the isoform frequency f(j) is set to
c(j)/(c(1)+c(2)+ ..+c(N) where c(j) denotes the normalized fragment coverage and
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N is the set of isoforms. For a detailed description of IsoEM model, refer to [114].
rQuant has implemented a different technique based on solving quadratic pro-
gramming and estimating different biases produced during the library preparation,
sequencing, and read mapping. The basic idea of rQuant is to minimize the deviation
of the observed read coverage from the expected coverage at each base by solving the
following optimization problem:










where T is the set of transcripts, w1, ...., wT are the transcript abundance estimates, P
is the set of genomic positions, Cp is the observed read coverage, and Dt,p is the read
density estimation for a transcript t at position p. If this model were used without
considering bias estimation then Dt,p = 1 in case transcript t is exonic at position p
and Dt,p = 0 otherwise. rQuant optimized the model by building a predictive model
for the density and finding parameters θ in which resulting read densities fit properly














where L represents the number of loci, Pi denotes the set of positions for each locus,
Dt,p(θ) is the θ is the read density parametrized for each transcript t at position p,
and R(θ) is a regulatory term used to avoid model overfitting [12].
4.3.2.3 Differential Expression (DE) Analysis
One of the primary applications in RNA-Seq is the study of gene expression
profiling across experimental conditions. The number of reads that map to a gene
is a direct measure of its expression at the transcription level. Thus, the study of
determining which genes have changed significantly in terms of their RNA expression
across biological samples is referred to as differential expression analysis. This step
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is essential in most RNA-Seq studies. Identifying which genes are differentially ex-
pressed (DE) between samples help researchers understand the functions of genes in
response to a given condition. In this section, we review the most recently developed
and widely used methods for differential expression analysis. We look at the different
statistical models each method uses to test for differential expression. Since a large
number of methods and tools have been developed in the last few years for DE analy-
sis, not all DE methods are discussed here, but instead, we put more emphasis on the
most widely used methods including DEGSeq [160], edgeR [132], DESeq [3], baySeq
[58], and Cuffdiff [154]. A comprehensive list of the DE methods can be found in
Table 4.2.
The detection of which genes have significant DE across samples requires the
use of statistical hypothesis tests to model RNA-Seq count data. For any DE anal-
ysis, three components should be considered: (1) normalization of read counts, (2)
statistical modeling of gene expression, and (3) testing for differential expression.
4.3.2.4 Normalization
In order to derive an accurate comparison within and between samples, nor-
malization is performed on read counts to adjust for sequencing depth variations and
other systematic technical variations which results in a comparable data across con-
ditions. Thus, to discover significant changes in expression, studies have shown that
normalization is an essential step in the analysis of differential expression. Several
normalization techniques have been proposed in the literature. Marioni et al. [100]
use the total read count (TC) to normalize read counts. This normalization method




is the number of reads for gene i in sample j and Nj is the number of reads in sample
j (library size). Such an approach is equivalent to the total intensity normalization
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Table 4.2: List of common differential expression Analysis methods.
Method Technique
DEGseq [160] MA-plots based method, assuming normal distribution for M | A.
edgeR [132] Exact test based on NB distribution.
DESeq [3] Exact test based on NB distribution.
baySeq [58] Empirical Bayesian method (compute posterior probabilities of models, based on Poisson or NB
distribution).
Cuffdiff [154] NB distribution to model the variance in fragment counts.
LRT [100] Likelihood ratio test based on Poisson model.
PoissonSeq [91] R package based on Poisson log-linear model.
GPseq [146] Likelihood ratio test for two-parameter generalized Poisson model.
NOISeq [151] Empirical approach to model the noise distribution of DE by contrasting fold-change differences (M)
and absolute expression differences (D) for all the features in samples within the same condition.
EBSeq [82] Empirical Bayesian approach that models a number of features observed in RNA-seq data.
SAMseq [92] Nonparametric approach for identifying DE in RNA-Seq data.
npSeq [92] Nonparametric approach for identifying DE in RNA-Seq data. Similar to SAMseq with only differ-
ence that npSeq uses symmetric cutoffs, while SAM uses asymmetric cutoffs.
NBPSeq [32] Negative Binomial (NB) models for two-group comparisons and regression inferences from RNA-
sequencing data.
ShrinkSeq [157] Bayes-empirical Bayes method that analyzes RNA-Seq data by estimating multiple shrinkage priors.
It supports a variety of count models such as NB mode.
TSPM [7] A Two-Stage Poisson Model for testing RNA-Seq data.
Limma [144] An R package that uses linear models for the analysis of gene expression data arising from microarray
or RNA-Seq technologies.
Alexa-Seq [52] A method to analyze RNA-Seq data to catalog transcripts and assess differential and alternative
expression of known and predicted mRNA isoforms in cells and tissues.
ASC [163] Empirical Bayes method to detect differential expression.
BBSeq [170] A method designed for the DE analysis of the RNA-Seq count data. The method incorporates two
approaches: (1) a simple beta-binomial generalized linear model, (2) mean-overdispersion model used
to capture the gene specific dispersion.
DiffSplice [66] An ab initio method for the detection of DE alternative splicing isoforms under different conditions
using RNA-seq reads.
QuasiSeq [98] An R package used to apply the QL (quasi-likelihood), QLShrink and QLSpline methods to quasi-
Poisson or quasi-negative binomial models for identifying DEGs in RNA-seq data.
BitSeq [47] A Bayesian approach for estimation of transcript expression level from RNA-seq experiments and
estimating differential expression (DE) between conditions.
MATS [140] A Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data.
Myrna [80] A cloud computing tool for calculating differential gene expression in large RNA-seq datasets. It
includes short read alignment with interval calculations, normalization, aggregation and statistical
modeling. It uses both parametric and non-parametric tests.
CEDER [158] An R package developed to detect DEGs using RNA-Seq by combining significance of exons within
a gene.
DEXSeq [4] An R package that finds differential exon usage based on RNA-Seq exon counts. It uses GLMs of
the NB distribution (NB-GLMs) to model exon counts.
SplicingCompass
[6]
A method to predict genes that are differentially spliced between two different conditions using
RNA-seq data. It uses geometric angles between the high dimensional vectors of exon read counts.
MISO [74] A probabilistic framework that quantiates the expression level of alternatively spliced genes from
RNA-Seq data, and identifies differentially regulated isoforms or exons across samples.
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procedure applied for microarrays. Similar to the TC method, Bullard et al. [16]
proposed a quantile normalization, borrowed from microarray technology, in which
the total counts is replaced by the upper quantile (UQ) of the counts. The main
concept of quantile normalization is to match the distribution of read counts in each
lane to a reference distribution defined in terms of median counts across sorted lanes.
Replacing the UQ by the median, another form of quantile-based normalization called
a median normalization is used. To correct for differences in library sizes and gene
length, Mortazavi et al. [109] introduced RPKM (Reads Per Kilobase of transcript
per Million mapped reads). The RPKM is defined as: RPKM = 109 × Cg
l(t)×N
,
where Cg is the number of reads mapped to gene g, l(t) is the length of transcript
t, and N is the total number of mappable reads in the sample. There are two cases
in this context to consider. In the first case when DE analysis is used to compare
genes within a sample (each gene is compared relative to other genes in the sample),
the length of the gene is important and should be considered for normalization to
avoid bias. This is clear since longer transcripts will by their nature have more read
counts. In this case, read counts should be normalized by gene length. RPKM has
been widely used to normalize read counts using both the library size and the gene
length. In the second case when DE analysis is applied to compare the expression
of the same genes in different samples, the gene length is not considered in the nor-
malization procedure. This is also clear since genes have the same lengths across
samples.
As an alternative to RPKM, Transcripts Per Million (TPM) [109] procedure
normalizes RNA-Seq data by dividing the number of reads of a transcript by the total
clone count of the sample multiplied by 106. Results using this method are reported
as reads/TPM for each sample. One of the limitations of TPM is the inability to
handle datasets marked with different RNA composition. Thus, another method
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called Trimmed Mean of M-values (TMM) was proposed by Robinson et al. [133]
as an attempt to remove RNA compositional bias. By estimating the relative RNA
production levels, TMM equates the overall expression levels of genes between samples
under the assumption that a large number of the genes are not differentially expressed.
To calculate the normalization scaling factor, this method uses a weighted trimmed
mean of the log ratios between two samples [133].
DE methods use different normalization procedures, some of which have im-
proved the procedures discussed above. For example, Marioni et al. use the TC
method; DEGSeq provides three choices for normalization, ’none’, ’median’, and
’loess’ (loess regression); Mortazavi et al. use RPKM; and Trapnell et al. imple-
ment a slightly modified version of RPKM called FPKM (Fragments Per Kilobase
of exon per Million mapped fragments) in their Cuffdiff method. R Bioconductor
packages such as edgeR, DESeq, and baySeq use different normalization approaches
as well. Whereas DESeq and baySeq use the library size, edgeR implements the
TMM method. DESeq uses the median of scaled counts (similar to the quantile nor-
malization) to estimate the normalization [78]. For each sample, the DESeq scaling
factor is computed for each gene as the median of the ratio of its read count over its
geometric mean across all samples [3, 126]. Using the assumption that most genes
are not DE, DESeq uses the median of ratios associated with each sample to obtain
the scaling factor. NOISeq, proposed by Tarazona et al. [151], uses several options
for normalization including TMM, RPKM, and UQ. Limma (Linear Models for Mi-
croarray Data) [144], an R package designed initially for DE analysis of microarray
data but lately adapted for RNA-Seq data, implements a quantile normalization ap-
proach. EBSeq [82] provides two choices for normalization, either by using the median
of scaled counts (used in DESeq) or a quantile normalization approach. PoissonSeq
[91] uses a normalization procedure which assumes a Poisson model for the data.
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4.3.2.5 Statistical Modeling of Gene Expression
The detection of which genes have changed significantly between biological
samples requires the use of statistical hypothesis tests to model count data from
RNA-Seq experiments. Currently, most statistical models are based on parametric
assumptions for modeling RNA-Seq data. Discrete probability distributions such as
binomial, Poisson, and negative binomial (NB) distributions have been used to model
RNA-Seq count data [78]. In RNA-Seq studies using a single source of RNA, the
distribution of counts across technical replicates for the majority of genes was indeed
Poisson [116, 78] in the form of f(n, y) =
(λne−λ)
n!
, where n is the number of read
counts and λ is the expected number of reads in each transcript [126]. Early methods
such as the Likelihood ratio test proposed by Marioni et al. [100], DEGSeq [160],
PoissionSeq, and Gpseq [146] have been developed to detect differentially expressed
genes based on this distribution. However, since the variance in this distribution is
equal to the mean, it suffers from the inability to capture biological variability within
RNA-Seq data [116, 78]. Given the fact that the variance of many genes is likely to
exceed the mean resulting in over-dispersion, Poisson-based analyses using biological
replicates will be prone to high false positive rates and therefore this distribution will
be impractical in this situation.
To address over-dispersion and account for biological variability, methods such
as edgeR, DESeq, baySeq, and Cuffdiff have been developed based on the negative
binomial distribution (NB) to model read counts. These methods address over-
dispersion by defining the relationship between the variance v and mean µ. For
example, edgeR and DESeq define this relationship as v = µ + αµ2, where α is the
dispersion factor. edgeR provides two options for α, a common dispersion (estimated
from all genes) and tagwise dispersion (estimated for individual genes) [132, 78, 42].
DESeq on the other hand estimates the dispersion parameter by using a combination
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of two terms for the variance, one to estimate the Poisson (the mean expression µ)
and the second is the raw variance of the gene used to model the biological expression
variability [3, 126]. Cuffdiff computes two variance models, i.e., one for single-isoform
genes and one for multi-isoform genes. For single-isoform genes, Cuffdiff computes
the expression variance similar to DESeq using NB distribution. When a gene has
multiple isoforms, Cuffdiff models over-dispersion by using the beta negative bino-
mial distribution [154]. BaySeq differs from the above three methods and implements
an empirical Bayesian model based on NB distribution. This model estimates the
prior probability parameters by bootstrapping from the data and then applies the
maximum likelihood method. PoissonSeq models RNA-Seq count data by using a
Poisson log-linear model. The mean µij in this model is defined as a log-linear model
logµij = logdi+ logβj +γjγi , where di is the library size of sample i, βj is the expres-
sion level of gene j, and γj is the correlation of gene j with condition γi [100, 91, 126].
γj = 0 if there is no association between gene j and γi, and γj 6= 0 otherwise.
4.3.2.6 Testing for Differential Expression
Once the parameters are estimated, statistical tests such as t-test, Wilcoxon
test, or Fisher’s exact test (FET) can applied on the normalized data to detect signif-
icant differentially expressed genes between samples. Both DESeq and edgeR use a
variation of the FET adopted for a negative binomial distribution. Cuffdiff compares
the log ratio of gene expression in two conditions against the log ratio of one condition
and calculates the test statistics as T =
E[log(y)]
V ar[log(y)]
, where y is the log ratio of the
normalized counts between the two conditions (Y =
FPKMa
FPKMb
). baySeq employs an
empirical Bayesian approach to determine DE between conditions. For every gene,
baySeq estimates two models, one model assumes the expression pattern is the same
and the second assumes the expression pattern is different across conditions. Thus,
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the posterior likelihood can be estimated using the prior estimates and the likelihood
of the distribution of the data to decide if a gene is differentially expressed. Pois-
sonSeq tests for DE by determining the significance of the correlation term Yj in the
linear model using a score statistic [126, 91]. The p-value is then derived using a chi -
square distribution since the score statistic is shown to follow this distribution. Other
DE methods use different statistical tests to test for DEGs. For example, limma uses
a moderated t-statistic test to derive the p-value.
4.3.2.7 Differential Expression Analysis Methods
In this section, a number of the most recently developed and widely used
methods for differential expression analysis are discussed as a related work of our
approach.
Cuffdiff
Cuffdiff is a Cufflinks module that aims to find significant changes in transcript
expression, splicing, coding output, and promoter use. It uses the Cufflinks transcript
quantification module to calculate transcript/gene expression levels and tests for sig-
nificant changes. The main input of Cuffdiff is the reference transcripts as a Gene
Transfer Format (GTF) file and two or more SAM (Sequence Alignment/Map) or
BAM (binary version of SAM) files containing fragment alignments for two or more
samples. The output of Cuffdiff is a set of several files containing changes in expres-
sion at the level of isoforms, primary transcripts, and genes. To test for DE, Cuffdiff
compares the log ratio of gene expression in two conditions against the log ratio of one
and calculates the test statistics. This ratio requires the knowledge of the variance of









where V ar[Xt] is the variance in the number of fragments coming from the transcripts
across replicates. Cuffdiff uses the negative binomial distribution (NB) to model the
variance in fragment counts across replicates and the square root of the Jensen-
Shannon (JS) divergence to quantify the changes in relative abundance. Thus, if we






and the JS divergence between a set of m distributions p1, p2..., pm is defined as:
JS(p1, ..., pm) = H
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Based on this JS divergence, Cuffdiff assigns p-values to the observed changes.
edgeR
The R Bioconductor package, edgeR was initially developed for SAGE but
since the methods are applicable to RNA-Seq, it has been also used for detecting
differential expression in RNA-Seq data. The edgeR is based on the negative binomial
distribution (NB) if data are over-dispersed. However, in cases where there is no
over-dispersion, the Poisson model is used. The edgeR count model is defined as:
Ygij ∼ NB(Mjpgi, φg), where Ygij represents the observed data for gene g in sample j
and experimental group i. The parameter Mj denotes the total number of reads in a
sample (library size) whereas the parameter pgi represents the relative abundance of
gene g in group i. φg is the dispersion parameter. In the case of over-dispersion, the
NB model is parameterized with the mean µgi = Mjpgi and variance v = µgi + µ
2
giφg.
However, in the case of no over-dispersion (φg = 0), the NB model is reduced to
Poisson model. The main input to edgeR is a table of counts constructed as a matrix
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whose rows represent biological feature (e.g. genes, transcripts, or exons) and columns
represents different samples. The output is a list of differentially expressed genes.
DEGSeq
DEGSeq is another R Bioconductor package developed for RNA-Seq data.
The statistical model this package uses is based on a Poisson distribution. Two
novel methods have been proposed in this package, an MA-plot-based method with
random sampling and an MA-plot-based method with technical replicates where M
is the log ratio of the counts between two conditions for gene g and A is the average
of the log concentration of the gene in the two groups [42]. Along with those two
methods, three existing methods, Fisher’s exact test (FET), likelihood ratio test
(LRT), and samWrapper have been integrated into DEGSeq to identify differential
expressed genes. In the MA random sampling, RNA sequencing can be modeled as
a random sampling process where each read is sampled independently and uniformly
from every possible nucleotide in the sample. Thus, the number of reads coming from
a gene/transcript follows a binomial distribution, which can be approximated by a
Poisson distribution. With this assumption, DEGSeq is not applicable to data with
over-dispersion which limits its use for RNA-Seq analysis. The input of this package
is uniquely mapped reads, a gene annotation of the corresponding genome, and gene
expression counts for each sample. The output includes a text file containing the
gene expression values for the samples, p-values, and two kinds of q-values (adjusted
p-values) and an XHTML summary page.
DESeq
DESeq is an R Bioconductor package that analyzes RNA-Seq count data using
the negative binomial distribution and an estimator of the distribution’s variance.
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DESeq uses a similar statistical model to edgeR with a few extensions allowing for
more general data-driven relationships of variance and mean. Under the assumption of
a locally linear relationship between variance and mean expression levels, the variance
can be estimated using data with similar expression levels [78]. The input of DESeq
is a table of count data that reports for each sample the number of reads that have
been assigned to a gene. Thus, a table cell in the i -th and j -th column represents the
number of reads mapped to gene i in sample j. The output is a list of differentially
expressed genes with p-values and q-values. The NB distribution DESeq uses to
model count data is defined as: Kij ∼ (µij, σ2ij), where Kij denotes the read counts
for gene i in sample j. This model has two parameters, the mean µij and the variance
σ2ij. These two parameters are often not known in advance and therefore have to be
estimated from the data. The mean µij can be defined as: µij = qi,ρ(j)sj, which is
the product of the expected read count (per gene and condition) qi,ρ(j) and size factor
sj which represents the coverage of library j. ρ(j) is the experimental condition of
sample j. In contrast, the variance is defined as:
σ2 = µij + s
2
j .vi,ρ(j)︸ ︷︷ ︸
raw variance
where vi,ρ(j) is the per gene raw variance parameter. This parameter is assumed to
be a smooth function of qi,ρ and defined as: vi,ρ(j) = vp(qi,ρ(j)), which should allow
the pooling of data from genes with similar expression strength. To perform testing,
DESeq uses Fisher’s exact test (FET) on NB data. Thus, for two conditions A and B,
the null hypothesis for a given gene is that the counts of the two conditions are equal
(qiA = qiB). The test statistic is performed using FET and the p-values computed










where kiA and kiB are the total read counts in each condition and kis = kiA + kiB.
Variables a and b denote the even probabilities for any pair of numbers a and b. For
more details about the computation methods of the above model, refer to DESeq in
the work of Anders and Huber [3].
baySeq
baySeq is an R Bioconductor package that assumes the data follows a negative
binomial distribution. baySeq differs from the above two packages in the strategy of
estimating significance by employing an empirical Bayesian approach to determine
differential expression across conditions. The baySeq approach starts by first boot-
strapping to estimate prior parameters from the data and then assessing posterior
likelihoods of the models by applying either maximum likelihood or quasi-likelihood
methods [42]. In general, the baySeq approach aims to identify the behavior of sam-
ples in terms of similarity and difference for each given model. Thus, for each gene
there will be two hypotheses either the expression pattern is the same or different
between two conditions. Under those two hypotheses, the posterior likelihood can
be estimated using the prior estimates and the likelihood of the distribution of the
data to decide if a gene is differentially expressed. The statistical models of bay-
Seq are based on both Poisson and NB distributions. The Poisson distribution is
defined as Ygij ∼ (Mjpgi) assuming that the prior pgi follows a gamma distribution
pgi ∼ Γ(αgi, βgi). The second model which is based on NB distribution is defined as
Ygij ∼ NB(Mjpgi, φg). The baySeq package accepts the table of read counts (similar
to DESeq, DEGSeq, and edgeR) assigned to each gene for each sample as an input
and reports a list of differentially expressed genes as an output.
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CHAPTER 5
IBSEQ: AN ISLAND-BASED APPROACH FOR RNA-SEQ
DIFFERENTIAL EXPRESSION ANALYSIS
5.1 Introduction
As discussed in Chapter 4 Section 4.3.2.3, the main application of RNA-Seq
is the study of which genetic features are significantly differentially expressed across
biological samples. It has been the most extensively investigated application for
RNA-Seq studies. Uncovering which features are significantly differentially expressed
between samples can provide insight into their functions. With the large magnitude
of data generated by next-generation sequencing technologies, a significant effort has
been made during the past few years to develop computational approaches that can
accurately and quickly detect the significant change in expression across samples. The
majority of the developed methods have been designed based on parametric statistics
in which discrete probability distributions such as binomial, Poisson, and negative
binomial are used. Table 5.1 shows examples of the current differential expression
methods along with their statistical models. Refer to Sections 4.3.2.5-4.3.2.7 for more
details about these methods.
One major limitation with the majority of these methods is they rely on ge-
nomic annotation. Thus, in order to detect which features are DE between samples,
these methods usually require an annotation file (e.g. GTF/GFF, BED, or count
table). The major drawback with this limitation is that any reads aligned outside
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Table 5.1: Examples of current differential expression analysis methods.
Method Statistical Model
Cuffdiff Negative binomial distribution to model the variance in fragment
counts
edgeR Exact test based on negative binomial distribution
DESeq Exact test based on negative binomial distribution
LRT Likelihood ratio test based on Poisson model
Gpseq Likelihood ratio test for two-parameter generalized Poisson model
DEGseq MA-plots based methods, assuming normal distribution for M | A
baySeq Empirical Bayesian to compute posterior probabilities of models,
based on Poisson or negative binomial data distribution
the annotated genome will be discarded and any significant change occurring outside
annotated regions will not be captured.
In this Chapter, a novel Island-Based approach, IBSeq, is presented as an
attempt to alleviate the issues resulting from relying on genomic annotation.
5.2 IBSeq Overview
In an attempt to overcome the limitation mentioned above and detect expres-
sion differences in any genomic region regardless of whether a genomic annotation
is available, we developed a novel Island-Based approach, IBSeq. The general work-
flow of this approach is shown in Figure 5.1 while Figure 5.2 describes the input and
output of each step in the approach. Generally, the method begins by dividing the
genome into small, fixed, non-overlapping regions (windows) which are then classified
into high and low density regions based on their underlying read count. Contiguous
adjacent regions with similar densities are merged together to construct larger re-
gions called islands. Constructed island locations are then mapped between samples
in order to refine island boundaries and tested for differential expression. Features
(typically genes) overlapping a set of DE islands are tested for DE by using combined
85
Figure 5.1: Workflow of the island-based approach.
p-value methods. DE islands that do not overlap with any features are considered
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Figure 5.2: The input and output of IBSeq steps.
5.2.1 IBSeq Framework Steps
5.2.1.1 Compute Per Base Abundance
To generate per base abundance (Figure 5.2, step 1), aligned short read se-
quences (often in the form of SAM/BAM format) are first converted into BED for-
mat (a tab-delimited text file that defines a feature track). Each BED file for each
sample is split by chromosome and a per base count is computed for each chro-
mosome separately using BEDTools [125]. Thus, if sj represents sample j, then
Csj represents the complete set of per base counts separately for each chromosome
Csj = {Csj ,chr1, Csj ,chr2, ..., Csjchrk}, where Csj ,chr1 is the per base count for chromo-
some 1, Csj ,chr2 is the per base count for chromosome 2, and so on for each of the
k chromosomes. The purpose of computing per base counts for each chromosome
has two advantages: (1) the process is much faster than considering all chromosomes
simultaneously and (2) the approach will have more flexibility to work with specific
chromosomes in case differential expression analysis needs to be performed for a par-
ticular chromosome.
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5.2.1.2 Genome Partition and Region Classification
In step 2, region construction (or genome partition) begins by first summarizing
per-base read counts, generated in step 1, over a fixed window to minimize small
variance in coverage due to noise (Figure 5.2, step 2). The size of the window is
allowed to vary using smaller window sizes (10-60bp). Thus, for each sample sj, a set
of regions Rsj is constructed from the set of per base counts Csj for each chromosome.
Rsj = {Rsj ,chr1, Rsj ,chr2, ..., Rsjchrk}. Once the genome is split into windowed regions,
each region is classified as high or low density (density is based on the number of
reads in this context) using an average threshold t adapted from Zang et al. [166].
Thus, regions with read counts above or equal to the threshold t are classified as
high density regions and regions with read counts below the threshold are classified
as low density regions. The threshold t is sample specific and is defined based on a
user-defined p-value and the probability quantile function of the Poisson distribution
as an approximation for the expected number of reads:
∞∑
k=t
P (k, λ) ≤ p-value
where k is the number of reads in a window and λ represents the average number of
reads across all regions in the genome and calculated as λ = wSj/G, where w is the
region size, Sj is the total number of reads in experiment j, and G is the effective
genome length.
5.2.1.3 Island Construction
In the island construction process, preliminary islands (or pre-islands) are con-
structed for each sample by merging contiguous regions with similar densities. High
density pre-islands are constructed from adjacent high density regions and similarly
low density pre-islands are constructed from adjacent low density regions (Figure 5.2,
step 3). Generally, the high density pre-islands are constructed from the set of the
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high density regions Rhigh,sj and low density pre-islands are constructed from the low
density regions Rlow,sj . Thus, the complete set of pre-islands in sample sj is defined
as:
Isj = {Isj ,chr1, Isj ,chr2, ..., Isj ,chrk}
The low density regions denote the start and end points for individual high density
pre-islands. Each high density pre-island is allowed to include a number of low density
regions based on a pre-defined cost threshold c (or gap size). Figure 5.3 shows an
example where one low density region is allowed in a given pre-island.
Figure 5.3: Illustration of pre-island definition [166]. Regions are shown as genome
coordinates along the x-axis with each bar representing one region. The y-axis denotes
the read count for each region. The orange bar denotes the constructed islands using
a threshold t = 5 (red line) and a gap size 1. The blue boxes show low density regions
included in that pre-island.
5.2.2 Island Differential Expression Testing
The primary goal of island DE testing is to test the null hypothesis H0 that
an island has the same expression level between samples versus the alternative hy-
pothesis H1 that an island has a significant difference between samples. In order to
perform this test, constructed pre-islands are overlapped between each two samples
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(pairwise comparison) and split into smaller islands where the start and stop loca-
tions are different as shown in Figure 5.4. Each island then comprises an overlapping
Sample 1
Sample 2
Pre-island 1 Pre-island 2
Pre-island 1 Pre-island 2
Overlapping 
regions (islands)




Figure 5.4: Illustration of overlapping islands between samples. The overlapping
region (island) has to correspond to a high density pre-island in at least one sample
to be considered for the DE test. Overlapping regions constructed from low density
pre-islands in both samples are removed and not considered for the DE test.
region between the two samples that can be subsequently tested for differential ex-
pression between conditions using statistical tests such as a parametric t-test or a
non-parametric Wilcoxon test (Figure 5.2, step 4). Islands constructed from low den-
sity pre-islands across samples are removed and only islands constructed from high
density pre-islands in at least one sample are kept. To conduct an accurate compar-
ison, read counts are first normalized based on the total number of mapped reads
in each sample. We call this normalization method Islands Per Million (IPM) (an
adaptation form of the well-known method transcripts per million (TPM)). The IPM





where Kij is the read counts of island i in sample j and Mj is the total number of
mapped reads for sample j. Since islands tested for DE have the same length, it is not
needed to include the island length in the normalization computation. To test for DE
islands across the two samples, two statistical tests Welch’s t-test and Wilcoxon test
are used on the normalized IPM values. The Welch’s t-test is an adaptation of the
90
well-known Student’s t-test in which the test assumes the two samples have unequal





















where X i represents the ith island mean, s
2
i represents the ith island variance, and
Ni represents the ith island size. As an alternative to the parametric Welch’s t-test,
we also perform a nonparametric Wilcoxon Rank-Sum test (also known as Mann-
Whitney U test). The Wilcoxon test is based on the ranks of the observations and
not the raw data. The test-statistic, T , is calculated as the sum of ranks in the smaller
group. To understand this test, suppose that N1i, ..., Nni represents the read counts
of islands i in n samples. If Rij(N) is the rank of all counts Nij, the Wilcoxon test




where N = n1 + n2 and n1 is the length of the island in the first sample.
5.2.3 Combined Significance of DE Islands
To detect which genetic features (e.g. genes) are differentially expressed be-
tween samples, the significance of DE islands that overlap with each feature is com-
bined using combined p-values methods (e.g. Fisher’s method). DE islands that do
not correspond to any feature are considered novel DE regions. Those regions are
annotated along with their closest features. In IBSeq, six combined p-value methods,
shown in Table 5.2 and detailed in Chapter 6, are implemented.
5.2.4 IBSeq Algorithm
The IBSeq approach as described above consists of a number of steps to perform
the differential expression analysis. From the computer science perspective, these
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Table 5.2: Combined p-value methods implemented in IBSeq.
Method Description
Fisher’s [40] χ2F = −2
k∑
i=1
ln(pi). If the null hypothesis H0 is true for
all k tests, χ2F will have a chi -squared distribution with 2k
degrees of freedom.




. If the null hypothesis H0 is true for all k tests,
Z will have a standard normal distribution.






. Generalized form of the Z-transform
method.
Minimum P-value [153] P = 1− (1− p[1]))n. if p[1] is the minimum of p1, p2, . . . pn,
then p[1] has a beta distribution with parameters 1 and n
in case H0 is true for all n tests.

















, where p is the p-value and l is the island
length.
steps are the algorithm processes needed to perform a task which can be represented
as a flowchart (Figure 5.5). The corresponding pseudocode of the IBSeq algorithm
flowchart is depicted in Algorithm 1.
5.3 Experimental Results
In order to examine the performance of the IBSeq approach, we conducted a
gene differential expression analysis using available RNA-Seq data described below.
To evalaute its performance, the IBSeq was compared to a number of current gene
DE methods including Cuffdiff, DESeq, and edgeR. Although we have implemented
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Figure 5.5: The flowchart of IBSeq algorithm.
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Algorithm 1 IBSeq Algorithm
Input: set of aligned RNA-Seq reads A for m replicates R in n samples S
A = {{As1,1 , .., As1,m}, {As2,1 , .., As2,m}, ....., {Asn,1}, .., {Asn,m}}
Output: set of differentially expressed islands I across samples.
set of known differential expression features F across samples S
set of novel differential expression regions N across samples S
1: while T 6= ∅ do
2: for each sample si ∈ S do
3: for each replicate rj ∈ R belong to Si do
4: convert alignment SAM file asirj into BAM bsirj
5: convert BAM bsirj into BED dsirj and split dsirj by chromosomes
6: compute per base count set Csirj for replicate rj ∈ Si from BED file dsirj
Csirj = {Csirj ,chr1, Csirj ,chr2, ..., Csirjchrk}
7: construct a set of regions Gsirj for replicate rj ∈ Si from Csirj
Gsirj = {Gsirj ,chr1, Gsirj ,chr2, ..., Gsirjchrk}
8: end for
9: combine replicate files r ∈ Si → Gsi
10: construct a set of islands Isi for sample Si from Gsi
Isi = {Isi,chr1, Isi,chr2, ..., Isi,chrk}
11: end for
12: /* Test for DE islands between N conditions (for each pair si, sj ∈ S) */
13: for i ← 1 to N do
14: for j ← 1 to N do
15: overlap the set of islands Isi , Isj between si, sj
16: fetch read counts for each overlapped region from Gi, Gj
17: test for DE islands between si, sj (IDE ← IDE(si,sj))
18: end for
19: end for
20: /* combine the significance of each comparison */
21: for each comparison si, sj do
22: overlap IDE with annotation GTF/BED and computer overall significance
for each feature F
23: compute novel DE regions Gnovel(si,sj)
24: end for
25: end while
six combined p-value methods, only Fisher’s method was used in this analysis since
the aim is to compare the performance of the IBSeq to the current methods. Chapter




To test the performance of the IBSeq, two datasets related to the MicroArray
Quality Control (MAQC) Project [142] were obtained. The experiments in the two
datasets analyze two biological samples: Ambion’s human brain reference (Brain) and
Stratagene’s human universal reference RNA (UHR) [16]. In both datasets, the two
samples were prepared using one library preparation and sequenced in seven lanes
and two flow-cells using an Illumina Genome Analyzer II (GAIIx). The first dataset
was sequenced with RNA-Seq reads of length 35bp with only one biological replicate
[16]. This dataset was obtained from NCBI’s Sequence Read Archive (SRA) with
Accession IDs: SRX016359 and SRX016367 for Brain and UHR respectively. The
second dataset was sequenced with 50bp RNA-Seq read length with one biological
replicate [113]. This dataset was obtained from SRA with Accession IDs: SRX027129
and SRX027130 for Brain and UHR respectively.
5.3.1.2 qRT-PCR Datasets
As part of the MAQC project, 1044 genes were selected to be assayed by
qRT-PCR. The expression of those genes were quantitatively measured for Brain
and UHR samples using TaqMan Gene Expression Assay [16, 158]. This data is
used as a “gold-standard” to evaluate the performance of IBSeq for detecting DEGs
obtained from Gene Expression Omnibus (GEO) with series ID GSE5350. Four repli-
cates were obtained for Brain (GSM129638-GSM129641) and four replicates for UHR
(GSM129642-GSM129645). We removed genes whose identifiers are not present in
RefSeq resulting in a total of 1033 genes. We follow Bullard et al. [16] and Wan et
al. [158] for processing this data and compute the expression level of each gene for
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where ∆Ci,j = Ci,POLR2A − Ci,j denotes the original qRT-PCR expression (C is the
normalized threshold cycle number and POLR2A is the reference gene). This was
done to transform the original expressions, which are in log base-2, to the natural
logarithmic scale. The log-fold change is then defined as the difference of average
across the four replicates Y UHR,j−Y Brain,j. To define the DE genes (positive set) and
non-DE genes (negative set), genes with absolute log-fold change > 2 are considered
DE genes and genes with absolute log-fold change < 0.2 are considered as non-DE
genes. Out of 1033 genes, 309 genes fall in the positive set (true positives TP) and 174
genes in the negative set (true negatives TN). Genes with absolute log-fold change
> 0.2 and < 2 are discarded and not used in this study.
5.3.2 Evaluation of IBSeq Approach for Detecting DEGs
To test the performance of the IBSeq, the Receiver Operating Characteristic
(ROC) is used to evaluate the relationship between sensitivity (true positive rate)
and specificity (false positive rate). We evaluate the results of the IBSeq approach
for detecting DEGs by comparing it to three widely used methods: Cuffdiff, DESeq,
and edgeR. For each method, the p-value is used to determine which genes are DE
and which ones are not. Thus, for a given p-value threshold, we consider genes
with p-values smaller than or equal to the threshold as DE genes and genes with
p-values greater than the threshold are non-DE genes. Using the qRT-PCR data as a
“gold-standard”, the predicted results are compared to the set of 483 genes generated
in Section 5.3.1.2 and true positive rate (TPR) and false positive rate (FPR) are








where TP denotes the true positive, FN is the false negative, and TN is the true
negative sets. Using this information, we generate ROC curves for all methods based
on different p-value cutpoints using both datasets I and II. We use the area under the
ROC curve (AUC) calculated using the trapezoidal rule to measure the accuracy of
each method and evaluate the performance for detecting DEGs.
5.3.3 Construct Islands and Test for DE Islands
To construct islands, short read sequences of the two samples Brain and UHR
in each dataset were first mapped to reference genome (hg19) using Bowtie [79] with
the default parameters allowing for two mismatches. To construct regions, we applied
a window of size 30bp. To classify regions, the average thresholds for the two samples
were computed using a p-value of 0.05 resulting in t = 3 for both samples. Thus,
regions with read count above or equal to 3 reads were classified as high density
regions and regions with read counts below 3 reads were classified as low density
regions. Using t = 3 and c = 1 (c is the gap size), islands were constructed for Brain
and UHR samples for each dataset. Table 5.3 shows detailed information about the
constructed islands for each sample in the two datasets.
Table 5.3 indicates that the average length of low density islands is much larger
than the average length of high density islands which agrees with the fact that a large
portion of the human genome (about 98%) is non-coding and only about 2% is coding
regions. Thus, the coding regions (transcribed regions) should fall within high density
islands. To test for DE islands, two statistical tests Welch’s t-test and Wilcoxon test
were applied to compute the test statistics T and the p-values.
97
Table 5.3: Detailed information of constructed islands.
Dataset I
Sample Number of Islands Average Island Length
High Low High Low
Brain 389,376 389,399 78.4487 3896.63
UHR 391,680 391,703 80.0481 3871.65
Dataset II
Sample Number of Islands Average Island Length
High Low High Low
Brain 465,298 465,321 86.0159 3240.47
UHR 446,156 446,179 87.2413 3381.96
5.3.4 Combined Significance of DE Islands
Since all the methods being compared report results at the gene level, an overall
p-value for a gene needs to be generated from the island p-values. Therefore, the p-
values of the islands overlapping with each gene are combined using Fisher’s method
[40]. Fisher’s method computes the overall p-value p by combining the significance of







where pi is the p-value of the ith island and k is the number of islands tested. Thus, if
none of the islands are DE, the p-values pi are independent and uniformly distributed
on the unit interval pi ∼ U(0, 1) which indicates the null hypothesis H0 is true. Hence,
χ22k,p denotes the upper p point of the probability of a chi-squared distribution with
2k degrees of freedom [158, 28, 62].
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5.3.5 Evaluation and Comparison
The performance of IBSeq approach was evaluated using the benchmark RNA-
Seq datasets for the Brain and UHR samples. The portion of the qRT-PCR data that
we selected in Section 5.3.1.2 with 309 genes in the positive set (true DE) and 174
genes in the negative set (true non-DE) was used to compare the results of the IBSeq
to the other DE methods. Since our approach is based on combining the p-values of
islands overlapping with the genes, for all methods, the p-value was used as a measure
of significance in this study.
When we computed the overall p-values for the two sets of genes, using dataset
I, for the true DE set with 309 genes, nine genes were missing (none of the islands
overlapped with those genes) and 22 genes were missing from the true non-DE set
with 174 genes. Per base counts for each of these missing genes were checked and it
was determined they have low counts and consequently their corresponding islands
were classified as low density and therefore were removed. To verify this conclusion,
we compared the counts in Cuffdiff and in the DESeq and edgeR count table. We
found a strong agreement between our approach and the other methods in terms of
low read counts. For instance, Cuffdiff reported that out of the 9 missing genes, 8
genes were not tested (NOTEST) indicating there were too few counts to perform a
significance test and similarly out of 22 missing genes, 20 were not tested for the same
reason. Giving this strong evidence these genes are not DE between the two samples,
they were treated as non-DE genes and counted as false negatives (FN) for the nine
missing genes and as true negatives (TN) for the 22 genes. Similarly with dataset II,
8 genes were missing in the positive set and 25 genes were missing in the negative
set due to low counts. Results from Cuffdiff supported our approach in that Cuffdiff
described all those genes as NOTEST which indicate the low counts. We performed
the same filtering for dataset II and included those genes in the false negative set
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and true negative set in the calculation of true positive and false positive rates. In
order to compare IBSeq with other existing DE methods, we performed differential
expression analysis for the same MAQC datasets (I and II) using Cuffdiff, DESeq,
and edgeR and computed the p-values for the set of 483 (309+174) genes. With the
exception of Cuffdiff, the differential expression analysis of DESeq and edgeR were
performed using the same count table of all genes annotated in RefSeq. This count
table was generated using htseq-count version 0.5.4p1 [5] with the same RefSeq
GTF file downloaded from the UCSC genome browser.
For the set of 483 genes, first we looked at the p-value distribution (Figure 5.6)
generated by each method using dataset I and dataset II. Using a p-value cutoff ≤
0.05 (5%), we could observe that our approach performs well in detecting the true DE
genes whereas it performs slightly worse in detecting the true non-DE genes. This is
illustrated in Figure 5.6 where the p-value histograms of the IBSeq is highly skewed
to 0 indicating that a large number of true DE genes will be detected (giving the fact
that approximately 65% of the gene set falls in the positive set). Since this histogram
is slightly skewed far from 0, there is a high possibility that the IBSeq approach will
not perform well in detecting true non-DE genes. In contrast, the p-value histograms
of Cuffdiff, DESeq, and edgeR were not as highly skewed to 0 as the IBSeq approach
indicating the likelihood of not performing well in detecting true DE genes. However,
the histograms show a moderate shift toward 1 meaning those methods will perform
well in detecting true non-DE genes.
Although Cuffdiff, DESeq, and edgeR did not perform well in detecting true
DE genes, they were excellent in detecting almost the complete set of the true non-
DE genes with 172, 173, 171, respectively out of 174. Table 5.4 shows the number
of true positive (TP) and true negative (TN) genes detected by each method using a
p-value ≤ 0.05 and Figure 5.7 shows the bar graph of those numbers.
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(a) MAQC dataset I






































































(b) MAQC dataset II
Figure 5.6: The distribution of p-values for the four methods (IB=IBSeq).
Table 5.4: Number of true DE and true non-DE genes found by each method using
p-value ≤ 0.05.
Method TP(D I) TP(D II) TN(D I) TN(D II)
IBSeq TTest 282 291 113 80
IBSeq Wilcoxon 269 280 149 128
Cuffdiff 190 176 172 173
DESeq 136 134 173 173
edgeR 193 185 171 172
Table 5.4 indicates that the IBSeq approach performs well in detecting TP
genes whereas Cuffdiff, DESeq, and edgeR were much better in detecting the TN
genes. As we see in Table 5.4 and Figure 5.7, the IBSeq approach was not able to
detect a high number of true non-DE genes like other methods. DESeq and edgeR
performed similarly since both methods use similar statistical tests (a form of Fisher’s
exact test) and both model read counts by using a negative binomial distribution
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Figure 5.7: Number of DE and non-DE genes detected by each method using p-value
≤ 0.05.
(NB). According to the DESeq documentation, DESeq is conservative in detecting
DE genes. Thus, it is of no surprise we do not see a large number of true DE
genes detected by DESeq. To plot the ROC curves for the four methods, we set
different thresholds of the p-values and calculated the true positive rate (TPR) and
false positive rate (FPR) for each method. Generally, a method that performs better
will give a ROC curve with higher TPR than other methods with the same value of
FPR. We computed the AUC and use it as a measure to compare the performance
of each method. Figure 5.8 shows the ROC curves of the four methods on the two
MAQC datasets.
Looking at the AUC of each method in Figure 5.8, it is clear the two versions
of our approach (t-test and Wilcoxon) outperform other methods in both datasets.
IBSeq using the Wilcoxon test performed the best among the four methods with AUC
102





























(a) MAQC dataset I





























(b) MAQC dataset II
Figure 5.8: The ROC curves for the four methods using MAQC datasets.
= 0.897 for dataset I and AUC= 0.908 for dataset II. Similarly, IBSeq using Welch’s
t-test performs well in both datasets with AUC = 0.895 for dataset I and AUC =
0.871 for dataset II. Cuffdiff performed better than DESeq and edgeR but not as well
as IBSeq.
We further looked at the number of differentially expressed genes shared be-
tween each pair of methods (Table 5.5) for both datasets. This gives an indication
on the level of agreement between methods in detecting the true DE genes. Table 5.5
indicates a strong agreement in detecting true DE genes between the two versions of
IBSeq. Compared to other methods, both versions of IBSeq were able to detect almost
all true DE genes detected by other methods for the two datasets. For instance, out
of 190 true DE genes detected by CuffDiff, the IBSeq approach was able to detect 183
and 178 respectively for the two versions in the first dataset. In the second dataset,
the number is even higher as shown in Table 5.5. The same observation is applied for
DESeq and edgeR where almost all true DE genes detected by those methods were
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Table 5.5: Number of shared true DE genes detected by each method using p-value ≤
0.05. The diagonal represents the numbers of true DE genes detected by each method.
Dataset I
IBSeq TTest IBSeq Wilc. Cuffdiff DESeq edgeR
IBSeq TTest 282 268 183 135 186
IBSeq Wilc. 269 178 132 180




IBSeq TTest IBSeq Wilc. Cuffdiff DESeq edgeR
IBSeq TTest 291 279 173 134 181
IBSeq Wilc. 280 170 131 178
Cuffdiff 176 118 154
DESeq 134 134
edgeR 185
also detected by our approach. This indicates the set of DE genes found by the IBSeq
contains a large number of DE genes found by other methods. To look at the overlap
between all methods and determine the number of true DE genes and true non-DE
gene shared between all methods, Figures 5.9 and 5.10 depicts the complete overlap
between the number of TP and TN genes detected by each method.
One caveat with the choice of the MAQC datasets is the ratio of DE to non-
DE genes is skewed in comparison to typical datasets where it might be expected
that only 5-10% of the genes are differentially expressed. These datasets were chosen
for comparative purposes since they contain experimental validation for differentially
expressed genes. That being said, we have also applied the IBSeq approach to whole
transcriptome RNA-Seq data as well (results not shown) for the datasets discussed
in Chapter 1 Figure 1.2. Initial results suggest a similar performance to the MAQC
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data with the majority of novel islands detected within or in close proximity to known
transcribed regions.
(a) TP for Dataset I (b) TP for Dataset II
Figure 5.9: Overlap between true DE genes found by each method.
(a) TN for dataset I (b) TN for dataset II
Figure 5.10: Overlap between true non-DE genes found by each method.
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5.4 Conclusion
In this Chapter, we presented a novel approach for detecting differential ex-
pression in genome regions that does not rely on genomic annotations. The key
idea of this approach is the segmentation methodology in which individual islands
of expression are constructed based on windowed read counts and compared across
experimental conditions to determine differential island expression. We illustrated
how this approach is used to detect differences in expression without requiring any
prior knowledge of isoforms where the only input to this approach is the raw data
(short read sequences). To assess the performance of our method, we conducted a
differential expression analysis using two benchmark MAQC RNA-Seq datasets. To
detect DEGs, Fisher’s method for combining the significance of multiple tests was
used. The performance of IBSeq approach was evaluated by comparing its results
to three widely used methods for differential expression analysis. IBSeq was able to
detect a high number of true DE genes using p-value ≤ 0.05 and performed the best
among the four methods based on ROC analysis. However, in detecting the true
non-DE genes, IBSeq did not perform as well as expected. Although the approach
has detected a reasonable number of the true non-DE genes, it was not as high as
the other methods considered. Considering the results obtained, IBSeq performs well
in terms of detecting true positives. However, it still leaves room for improvement in
detecting true non-DE genes which is intensively discussed in Chapter 7.
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CHAPTER 6
COMBINING THE SIGNIFICANCE OF GENOMIC
REGIONS - A COMPARATIVE STUDY
6.1 Introduction
One of the motivations of developing the IBSeq approach is that summarizing
read counts on the gene level tend to result in inaccurate detections since most genes
consist of multiple exons and therefore the distribution of read counts in exons for a
single gene can be different [158]. By taking into account the significance of different
regions in the gene, IBSeq can break down the gene region (or any genetic feature)
into multiple small regions and test for differential expression across those regions.
Then for each gene, we combine the significance of genomic regions overlapping with
that gene using well-known combined p-value methods. Figure 6.1 describes this
process. By doing that, each region in the overall gene region will participate in the
Gene 1  Gene 2  
Intergenic region5' 5'3' 3'
 P-value P-value P-value P-value
Combined P-
value
 P-value P-value P-value
Combined P-
value
 P-value  P-value
Islands with P-values 
Genome 
Overall p-value computed 
by combining Islands p-
values using combining p-
values methods.  
Figure 6.1: Example of combining p-values from multiple genome regions.
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computation of the overall gene significance based on its degree of importance. This
will ensure that regions in the gene will not be treated equally.
The concept of combining significance (p-values) from multiple tests has been
intensively discussed in meta-analysis techniques from different fields. In biological
experiments for instance, these approaches have been used to integrate results from
multiple studies to detect which genes (or any genetic features) are differentially
expressed across samples. As an example, Chapman and Whittaker [22] used several
combined methods to integrate results of multiple single nucleotide polymorphisms
(SNPs) tests in a gene or region. In differential expression analysis using microarrays,
the technique has been used to combine p-values from probe level tests of significance.
Hess et al. [62] proposed using Fisher’s method to combine the significance of probe
level tests to identify DE genes using Affymetrix arrays. Li and Tseng [83] proposed
an adaptively weighted statistics method to combine multiple genomic studies for
detecting differentially expressed genes.
Since IBSeq is based on combining the significance of islands corresponding
to each feature, to determine the performance of the implemented combined p-value
methods, we conducted a comparative analysis study to compare six combined p-
value methods using publicly available RNA-Seq datasets. The framework applied
here is similar to the one in microarray studies where specific methods are used
to combine the significance of probe sets for individual genes. Similarly, we used
combined p-value methods to aggregate the significance of islands corresponding to a
chromosomal region (e.g. gene, exon, transcript) as shown in Figure 6.1.
In this chapter, we present the results of this study. We first applied IBSeq
to test for island differential expression and compute the p-values for each “island”
using four MAQC datasets [16, 142, 113] and Marioni’s liver and kidney dataset [100].
In the next step, the significance of islands corresponding to each gene is combined
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using six p-value methods: Fisher’s, [40], Stouffer’s Z-transform [148], Weighted z-test
[110, 95], Minimum p-value [153], Logit [111], and Weighted-sum. To evaluate the
performance of each method, ROC curves were generated for each MAQC dataset
and auROC was used as a performance metric. On the liver and kidney dataset,
we evaluated the performance of each method by looking at the number of detected
genes that overlap with the original results presented in Marioni’s paper [100].
6.2 Methods
6.2.1 Combined P-value Methods
IBSeq was first applied to test for differentially expressed islands. We first
tested the null hypothesis H0 that an island has the same expression level across
samples versus the alternative hypothesis H1 that an island has a significant difference
between samples. As a result, for each island, a test statistic t and p-value p were
computed. To detect which genes were differentially expressed between samples, the
p-value of the islands overlapping with each gene in the annotation were combined
using six combined p-value methods. The use of combined p-value methods is based
on the assumption that p-values p1, p2, . . . , pn are independent for given samples [158].
In this study, six combined p-value methods (Table 5.2), Fisher’s, Stouffer’s
z-score, Weighted z-test, Minimum p-value, Logit, and Weighted-sum were used.
The first five methods are widely used methods for combining the significance from
multiple tests. The sixth method (the Weighted-sum) is our proposed method.
6.2.1.1 Fisher’s Method
Fisher’s method [40] combines the significance by using p-values from k inde-






where pi is the p-value of the i
th island and k is the number of islands corresponding
to the tested gene. Thus, when none of the islands corresponding to a specific gene
are DE indicating the null hypothesis H0 is true for all k islands, the test statistic χ
2
F
will have a chi-squared distribution with 2k degrees of freedom [162].
6.2.1.2 Z-transform Method
The Z-transform method (sometimes called Stouffer’s Z-Score, z-test, or Nor-
mal test) [148, 95] was proposed by Stouffer et al. in 1949. In this method, p-values
are first transformed to z-values Zi = Φ
−1(1−pi) where Φ is the cumulative distribu-






Therefore, when none of the islands corresponding to a specific gene are DE (H0 is
true for all k islands), Z will have a standard normal distribution [158].
6.2.1.3 Weighted z-test
The Weighted z-test [110] is a generalized form of the Z-transform method
explained above proposed by Mosteller and Brush [110] in 1954 and Liptak [95] in
1958. In this method, a nonnegative weight w is assigned to each z-value. The







If the weights of all tests are equal, this method is reduced to the Z-transform method.
Similar to Z-transform, if none of the islands within a specific gene are DE, then Zw
110
still has a standard normal distribution. Determining appropriate weights is an open
issue. However, it has been shown that the sample size of each test can be used as
the weight [95, 158]. Thus, we chose the square root of the length of each island li to
be the weight assigned (wi =
√
li).
6.2.1.4 Minimum p-value Method
The minimum p-value statistic [153] is another method for combining p-values
proposed by Tippett in 1931. In this method, if p[1] is the minimum of p1, p2, . . . pn,
then p[1] has a beta distribution with parameters 1 and n in case none of the islands
corresponding to a specific gene are DE [153, 158]. Tippett’s test procedure using the
smallest P[1] is computed as follows:
p = 1− (1− p[1]))n
He suggested that the combined null hypothesis H0 should be rejected at level α if




The logit test [111] was proposed by Mudholkar and George in 1979. Each
p-value in this method is transformed to a logit, ln( P
1−P ) and the combined logits are












and has standard Student’s t-distribution with 5k + 4 degrees of freedom.
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6.2.1.6 Weighted-sum Method
The Weighted-sum is a method we propose in this study. In this method,
we simply multiply each p-value p by the island length l and divide the total of
multiplications by the total length of all islands. Thus, if l1, l2, . . . , lk represents
the islands lengths corresponding to a specific gene and p1, p2, . . . pk are the island






In this study, five publicly available RNA-Seq datasets were obtained from
NCBI’s Sequence Read Archive (SRA). Among those, four datasets are related to
the MicroArray Quality Control Project [16, 142, 113] and the fifth dataset is the
widely used Marioni liver and kidney dataset [100]. All datasets are single-end reads
generated by Illumina GA/GAII . A summary of the datasets used in this study is
shown in Table 6.1.
Table 6.1: Summary of RNA-Seq datasets used in this study.
Dataset Acession Number (SRA) Read Length Total Reads
MAQC2 [16] SRX016359 35bp 81,250,500
SRX016367 35bp 92,524,365
MAQC2 [113] SRX027129 50bp 53,238,798
SRX027130 50bp 59,561,348
MAQC2 [16] SRX016366 35bp 81,250,481
SRX016368 35bp 92,524,400
MAQC3-UHR [16] SRX016369-SRX016372 35bp 183,797,505




The experiments in the four MAQC datasets analyze two biological samples:
(1) Ambion’s human brain reference (Brain) and (2) Stratagene’s human univer-
sal reference RNA (UHR). In MAQC2, each sample was prepared using one library
preparation and sequenced on seven lanes (7 technical replicates each) on two flow-
cells using an Illumina Genome Analyzer II (GAIIx). In the MAQC3 dataset, four
different UHR library preparations were sequenced on 14 lanes and distributed across
two flow cells [16].
We used the same qRT-PCR datasets described in Chapter 5 Section 5.3.1.2 as
a ”gold-standard” to evaluate the performance of the six combined p-value methods
with a slight change of selecting the genes. Since all genes in this dataset were
classified as present (P) if they were detected above threshold and absent (A) if they
were not, only genes with a ”P” flag across the four replicates of each sample were
used in this study. We also removed genes that do not correspond to unique RefSeq
identifiers. The expression level of each gene was computed the same as we did in
Section 5.3.1.2. As a result, 313 genes fall in the true DE set and 128 in the true
non-DE set. Genes with absolute log-fold change > 0.2 and < 2 are discarded and
not used in this study.
6.2.2.2 Marioni’s Liver and Kidney Dataset
This data, generated by Marioni et al. [100], is widely used for evaluating the
performance of RNA-Seq developed approaches. The goal of Marioni’s study was to
assess the technical variance within and between runs by estimating gene expression
differences between human liver and kidney RNA samples using multiple technical
replicates. Each sample was sequenced in seven lanes distributed across two runs
of the machine and two different cDNA concentrations (1.5pM, 3pM) using an Illu-
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mina Genome Analyzer. Only data sequenced at 3pM (five lanes per sample) cDNA
concentration was used in this study. Table 6.1 shows more information about this
data. The raw data for both liver and kidney along with 17,708 Ensembl transcripts,
mapped with the array probes, were obtained. Ensembl transcripts that are expired
or do not exist in the most current annotation version were removed resulting in
17,001 Ensembl transcripts. To improve the quality of this data, raw 36bp reads were
trimmed to 32bp before mapping as advised by the authors.
6.2.3 Differential Expression
The IBSeq approach was used to detect DEGs between the two samples for
each dataset. First, all raw sequencing reads in the five datasets were mapped to
the indexed reference genome (hg19) using Bowtie version 1.0.1 [79] with the default
parameters allowing for two mismatches, given that individual reads are ≤ 50 bp.
Note that in instances with longer reads, Bowtie2 provide a more optimal approach.
We applied Bowtie2 as well with no significant differences (results not shown). For
each dataset, the SAM alignment files resulting from mapping were converted into
BAM format and fed into the IBSeq for island differential expression. The IBSeq was
then used to test for island DE between the two samples (Brain and UHR for MAQC
data and liver and kidney for Marioni) in each dataset with the following parameters:
--window 35 --t-pvalue 0.05 --p-value 0.05 --gap 1
where --window is the window size, --t-pvalue is the p-value used to calculate the
classification threshold, --p-value is the p-value for determining significant differen-
tial expression, and --gap is the gap size.
To detect for gene DE, the p-values for islands corresponding to each gene in
the annotation files were combined using the six combined p-value methods described
in Section 6.2.1. For the MAQC datasets, the portion of qRT-PCR data we selected
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in Section 6.2.2.1 with 313 genes in the true DE set and 128 in the true non-DE was
used to compute the overall significance of each gene. For liver and kidney data, the
Ensembl transcripts with 17,001 genes used in the original paper were used to detect
for gene DE. The motivation for using the same Ensembl transcripts was to be able
to conduct a valid comparison with the results of the original paper and assess the
performance of each combined method.
6.3 Results
6.3.1 Results from Liver and Kidney
We evaluated the performance of the combined p-value methods using the
liver and kidney dataset. As suggested by the authors to improve the data quality,
four bases of each read sequence were trimmed resulting in a total of 32bp for each
read. Even with trimming, the alignment rate for the two samples were not as good as
expected with 57 % and 59 % for liver and kidney respectively. This low alignment was
also reported in the original paper. Marioni [100] has conducted a gene differential
expression analysis between the two samples using multiple sequencing replicates
generated by Illumina GA and compared the results to Affymetrix arrays results
using the same RNA samples. In their study, a set of 17,708 probe sets mapping
uniquely to 17,708 genes (out of 32,000) obtained from Ensembl database v.48 were
identified. By comparing five lanes of each sample, they identified 11,493 DE genes
at FDR 0.1% from the Illumina sequencing data and 8,113 (81% of those were also
detected from the Illumina) from the Affymetrix arrays. Given the fact that the
alignment rate is low for the two samples, in our opinion, these numbers seem too
large. however, our motivation of using this data is that it is widely used and has
detailed information about the expressions in both Illumina and Affymetrix. To
compare our results with the results presented in the paper, we first used IBSeq to
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compare the two samples and compute the overall p-value for the 17,001 (700 genes
were eliminated from the set because of their expiration in the database) genes in the
Ensembl transcripts using the six combined p-value methods. Table 6.2 shows the
number of differentially expressed genes detected by each method and the number of
overlapping genes with both Illumina and Affymetrix results using p-value < 0.001.
Weighted-sum was eliminated from this analysis due to its poor performance.
Table 6.2: Differentially expressed genes detected by each method using p-value <
0.001. Overlap column represents the overlap with both Illumina and Affymetrix re-
sults. The Overlap(%) column indicates the percentage of overlap out of the detected
genes.
Method DE Genes Overlap Overlap(%) Novel
Marioni Affymetrix 7942 N/A N/A N/A
Marioni Illumina 10133 N/A N/A N/A
Fisher’s 3734 2891 77% 843
Z-transform 1911 1464 76% 447
Weighted z-test 4733 3649 77% 1084
Minimum p-value 2414 1882 77% 532
Logit 2541 1951 76% 590
As expected, the Weighted z-test method performed the best with the highest
number of detected genes and highest overlap with Illumina and Affymetrix results
outperforming Fisher’s method. This supports the argument of Chen [23] that the
weighted z-test is superior to both Z-transform and Fisher’s method. The minimum
p-value and logit methods perform very similar with a slight improvement for logit.
Z-transform on the other hand did not perform as well as the others. To enhance
our conclusions and look at the performance of another approach, we ran Cuffdiff
[154] on the same data. Cuffdiff only detected 302 genes. Of those, 207 (68%) were
also detected by the other methods. Venn diagrams (Figure 6.2) show the overlap
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between each combined p-value method and Marionni Illumina, Marioni Affymetrix,
and Cuffdiff.
To see if the novel genes detected by each combined p-value method (Table
6.2, column 5) may have differential alternative splicing events between the two sam-
ples, we conducted an alternative expression analysis of liver and kidney using MISO
(Mixture of Isoforms) [74]. As a result, 701 mutually exclusive exons (MXE) DE
events were identified. To determine whether the novel detected genes are differen-
tially spliced genes between the two samples, the 701 identified events were overlapped
with the novel genes detected by each method. Table 6.3 shows the number of genes
determined to be differentially spliced genes among the novel genes detected by each
method.
Table 6.3: Differentially spliced genes for each method.
Method Novel Genes Differentially Spliced Genes
Fisher’s 843 146
Z-transform 447 54
Weighted z-test 1084 148
Minimum p-value 532 98
Logit 590 102
6.3.2 Results from MAQC Datasets
Next, using the four MAQC datasets along with qRT-PCR data, we evaluated
the performance of the six combined p-value methods. For each dataset, we conducted
a comparison analysis between the Brain and UHR samples. Using IBSeq, the islands
for the two samples in each dataset were tested and a p-value was computed for each.
Using the qRT-PCR data with 313 genes in the true DE set and 128 in the true
non-DE set as a ”gold-standard”, each method was evaluated based on the number
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(a) Fisher’s (b) Z-transform
(c) Weighted z-test (d) Minimum p-value
(e) Logit
Figure 6.2: Overlap between the number of genes detected by each combined p-value
method and Marioni’s and Cuffdiff results.
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of truly detected genes in both sets. Figure 6.3 shows bar plots for the true detection
of each method for the four MAQC datasets.

































(a) True DE Genes
































(b) True non-DE Genes
Figure 6.3: Number of true DE and true non-DE genes detected by each method for
the four MAQC datasets using p-value < 0.05.
As shown in Figure 6.3a, all compared methods except the Weighted-sum per-
formed similarly in detecting the true DE genes for the four datasets with a slight
outperformance by the Weighted z-test method. Out of 313 genes (the true DE set
selected in Section 6.2.2.1), the five methods were able to detect between 89%-94%
(280-295 genes) in the four datasets. In contrast, the Weighted-sum was too con-
servative and performed poorly with only 84, 98, 84, 107 true DE detected genes
respectively. For detecting the true non-DE genes, Figure 6.3b shows a clear outper-
formance by the Weighted-sum method over the other methods. Out of 128 genes (the
true non-DE set), the method was able to detect between 97%-99% (125-127 genes)
in the four datasets. Surprisingly, the Weighted z-test and Fisher’s method, which
performed the best in detecting the true DE genes, did not perform as well in non-DE
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detection. The Z-transform method had a better performance and outperforms the
Weighted z-test and Fisher’s method.
We then looked at the Receiver Operating Characteristic (ROC) to evaluate
the relationship between sensitivity (TPR) and specificity (FPR) of each method.
By using different p-value thresholds, we computed the true positive rate (TPR) and
false positive rate (FPR) for each method in the four datasets. Thus, genes with p-
values smaller than a given threshold are considered DE genes and genes with p-values
greater than or equal to the threshold are considered non-DE genes. For each dataset,
ROC curves (Figure 6.4) were generated for the six methods using different p-value
cutpoints. The area under the ROC curve (AUC), shown in each plot and calculated
using the trapezoidal rule, was used to measure the accuracy of each method and
evaluate the performance for detecting DE genes.
As shown in Figure 6.4, the ROC curves show a similar performance for each
of the six methods. By looking at the AUC of each method (Table 6.4), we observe
that the performance was similar with a slight advantage of a certain method in each
dataset. That outperformance was not significant enough to conclude that a spe-
cific method is the best among others. For example, in dataset 1, the logit method
performed better than others with an AUC of 0.867. The performance of Fisher’s
method and Weighted-sum was very similar to the logit method with an AUC of
0.842 and 0.848, respectively. In dataset 2, Weighted-sum along with Fisher’s per-
formed the best with an AUC of 0.835 and 0.831 respectively, outperforming the
Z-transform slightly. For dataset 3, the performance of Weighted-sum was still the
best with an AUC 0.858, outperforming the Z-transform (AUC=0.837) and logit
(AUC=0.830). Finally, for dataset 4, Z-transform performed the best with an AUC
of 0.828. Therefore, the compared methods performed similarly with a slight advan-
tage to the Weighted-sum method.
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ROC curves for Combining P−value Methods











Fisher (AUC= 0.842 )
Z−Trans (AUC= 0.815 )
Weighted−Z−Trans (AUC= 0.832 )
Min−Pvalue (AUC= 0.829 )
Logit (AUC= 0.867 )
Weighted−Sum (AUC= 0.848 )













ROC curves for Combining P−value Methods











Fisher (AUC= 0.831 )
Z−Trans (AUC= 0.823 )
Weighted−Z−Trans (AUC= 0.818 )
Min−Pvalue (AUC= 0.806 )
Logit (AUC= 0.815 )
Weighted−Sum (AUC= 0.835 )













ROC curves for Combining P−value Methods











Fisher (AUC= 0.824 )
Z−Trans (AUC= 0.837 )
Weighted−Z−Trans (AUC= 0.824 )
Min−Pvalue (AUC= 0.827 )
Logit (AUC= 0.830 )
Weighted−Sum (AUC= 0.858 )













ROC curves for Combining P−value Methods











Fisher (AUC= 0.806 )
Z−Trans (AUC= 0.828 )
Weighted−Z−Trans (AUC= 0.790 )
Min−Pvalue (AUC= 0.763 )
Logit (AUC= 0.814 )
Weighted−Sum (AUC= 0.812 )
Figure 6.4: ROC curves for the six combined p-value methods on the MAQC datasets.
Table 6.4: AUC for each method on the four MAQC datasets.
Methods Dataset 1 Dataset 2 Dataset 3 Dataset 4
Fisher’s 0.842 0.831 0.824 0.806
Z-transform 0.815 0.823 0.837 0.828
Weighted z-test 0.832 0.818 0.824 0.790
Minimum p-value 0.829 0.806 0.827 0.763
Logit 0.867 0.815 0.830 0.814
Weighted-sum 0.848 0.835 0.858 0.812
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6.4 Conclusion
In this comparative study, the performance of a number of combined p-value
methods on RNA-Seq data were assessed. Using five publicly available RNA-Seq
datasets, we compared the ability of six combined p-value methods: (1) Fisher’s, (2)
Z-transform, (3) Weighted z-test, (4) Minimum p-value, (5) Logit, and (6) Weighted-
sum methods for detecting differentially expressed genes. Applying the six methods
on MAQC datasets shows a similar performance for detecting the true DE genes with
an exception of the Weighted-sum method’s poor performance. Only the Weighted z-
test slightly outperformed the other methods. In contrast, the Weighted-sum method
performed the best in detecting the true non-DE, clearly outperforming the other
methods. When looking at the AUC in Figure 6.4, we see that the Weighted-sum
method was at or near the best performance. Unexpectedly, the Weighted z-test did
not perform as well as Fisher’s, Z-transform, and logit methods. However, with the
liver and kidney dataset, the Weighted z-test has performed the best among others
and has reported the highest number of detected genes and overlap with Marioni




In this dissertation, a novel Island-Based approach, IBSeq, for RNA-Seq differ-
ential expression analysis was developed as an attempt to mitigate some of the limita-
tions associated with the current state of the art DE methods. IBSeq was developed
in a way that no prior information of transcripts is needed and only raw data (short
read sequences) is required. However, with IBSeq, we still have the option of using
the annotation if needed. The core process in the IBSeq is the segmentation method-
ology where individual genomic regions (islands) of expression are constructed based
on windowed read counts and compared across biological conditions to determine
differential island expression. To determine if biological features are significantly dif-
ferentially expressed across samples, the significance of islands corresponding to each
feature are combined using six combined p-value methods. We presented a detailed
description of this approach and illustrated how IBSeq is used to detect differences
in expression without requiring any form of annotation. To assess the performance of
this approach, we conducted a gene differential expression analysis and compared the
results to a number of current DE methods using several publicly available benchmark
RNA-Seq datasets. Using ROC curves and the area under the ROC curve (AUC) as
performance metrics, IBSeq was able to perform better than other methods partic-
ularly detection of true DE events. However, in detecting the true non-DE genes,
IBSeq did not perform as well as the other methods, generating more false positive
detections (type I error). This has led us to conduct more investigation and look for
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possible improvements. Examples of these investigations (presented below) are the
parameters determination and further island segmentation.
7.1 Parameters-Determination Analysis
Since IBSeq is based on the use of several parameters and thresholds, the
detection accuracy will consequently be based on the values of those parameters.
Thus, choosing the optimal values would provide the best performance. Examples of
IBSeq parameters that need more investigation are:
1. The window size used for splitting the genome.
2. The p-value used for computing the classification threshold used to classify
genome regions into high and low density regions.
3. The number of low density regions included in the construction of high density
island (the gap size).
In order to improve the detection accuracy, a complete analysis to determine
the best value of each parameter is required. In this section, we present the analysis
we conducted to determine the best values for the three parameters mentioned above
using the same four MAQC RNA-Seq datasets described in Table 6.1 and the qRT-
PCR dataset described in Section 5.3.1.2.
7.1.1 Window Size Analysis
To determine the optimal window size for IBSeq, we performed a window-size
analysis using seven different window sizes, 10, 20, 30, 35, 50, 60, and 100. Figure
7.1 shows the ROC curves generated for this analysis.
Generally, the best window size is the one that detects a high number of truly
DE genes with fewer false positives. Therefore, using the four MAQC datasets, results
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Figure 7.1: ROC curves for different window sizes. The blue oval represents the region
that provides the best result.
show a window size in the range of 35-50bp (the blue oval region in Figure 7.1) works
best. This may indicate a correlation between the window size and the read length
since most NGS sequencers generate reads with a length close to this range.
7.1.2 Classification Threshold P -value Analysis
As discussed in Section 5.2, in order to compute the classification threshold to
classify regions into high or low density regions, the user needs to provide a p-value.
The computed threshold value will be based on this p-value. To determine what is
the best p-value, we conducted a similar analysis to the one for window size using the
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same MAQC datasets and seven different p-values, 0.001, 0.005, 0.01, 0.05, 0.1, 0.2,
and 0.5. Figure 7.2 shows for each MAQC dataset the true DE and non-DE genes
detected by IBSeq.
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Figure 7.2: True DE and true non-DE detections using different p-values.
Obviously, the best p-value is the one that generates a threshold that provides
the optimal trade-off between the true DE and true non-DE detections. This means
it should detect a high number of true DE genes without increasing the false positive
rate. From Figure 7.2, it is clear that a p-value of 0.05 provides the trade-off since
using a p-value above 0.05 does not provide significant improvement for detecting the
true DE but it does increase the false positive rate.
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7.1.3 Gap Size Analysis
In order to determine how many low density islands are included in the con-
struction of high density islands (the gap size), it is needed to run the IBSeq with
different gap sizes. Therefore, we conducted a gap size analysis using the same MAQC
datasets and five different gap sizes, 0, 1, 2, 3, and 4. Figure 7.3 shows the result of
this analysis.
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Figure 7.3: True DE and true non-DE detections using different gap sizes.
It is obvious from Figure 7.3 that the best result is generated when we do not
include any low density regions (the gap size is 0) in the construction of high density
islands. Once the gap size is increased (gap size >=1), we see a clear increase of the
false positive rate.
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7.2 Further Island Segmentation
Island segmentation produces a variety of island sizes, with some belonging to
a long category (2000-500,000 bases) while many others are small (< 2000 bases).
After performing several experiments, it is observed that one reason for having high
false positive rates is that long islands tend to overlap with more than one feature
(e.g. gene). In order to alleviate this issue, we performed further segmentation on all
islands exceeding 1000 bases.
The further segmentation algorithm uses the concept of standard deviation
(SD) σ as follows. First, σ is computed for the initial segment (the first 10 regions
in the island, R1-R10). Second, the read counts of the next region (the eleventh
region, R11) is compared to 2σ. If the region count is greater than 2σ and the
segment size is 10 (the segment should include at least 10 regions to be considered
for further segmentation), we construct a new island from the initial segment and
starts a new segment from R11. If the condition is not true, the region R11 is added
to the initial segment and a new σ is computed. This process continues until we
reach the last region in the island. Figure 7.4 shows the algorithm flowchart and
Algorithm 2 represents the corresponding pseudocode. To illustrate this process
further, Figure 7.5 shows an example of further island segmentation using a 30bp
window size. Applying this algorithm on the IBSeq approach using the same four
MAQC datasets, results show a significant improvement in reducing the false discovery
rate without effecting the true DE detections as shown in Figure 7.6.
Another important issue associated with IBSeq that needs more investigation
is the combined p-value method used to combine the significance of islands corre-
sponding to each feature. This process is very important since the final result of
detecting differentially expressed features between samples is based on the combined
p-value method used. To evaluate the performance of the six combined p-value meth-
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START
S = island size
N = set of islands in a given sample
island = 1
S > 1000?
While (island <= N)
island = island +1
R = number of regions in island
segment = {R1..R10}
SD =  segment standard deviation 
segment_size = 10
j = R11
Construct new island from 
“segment”
segment = jsegment = segment +  j
True




j = j + 1
False
STOP




Figure 7.4: Further segmentation algorithm flowchart.
ods, we conducted a comparative study presented in Chapter 6. As a result of this
study, we can conclude that the different combined p-value methods in general per-
form similarly. However, given the slight increase in performance of the Weighted
z-test method for detecting the true DE on MAQC data and the best performance
on liver and kidney data, we determined that it is important to assign weights to the
combined tests because of their significant effect on the process of combining indepen-
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Algorithm 2 Further Island Segmenation Algorithm
Input: a set of m islands I for n samples S
I = {{Is1,1 , .., Is1,m}, {Is2,1 , .., Is2,m}, ....., {Isn,1 , .., Isn,m}}
Output: A set of further segmented islands I across samples S.
1: while I 6= ∅ do
2: for each sample si ∈ S do
3: z ← Isi .size
4: if z > 1000bp then
5: R← number of regions in island Isi
6: segment = {R1..R10}
7: sd = standard deviation of segment
8: segSize ← 10
9: for i ← R11 to R do
10: if Ri > 2*sd and segSize >= 10 then
11: construct a new island from segment
12: segment = Ri
13: else
14: segment = segment + Ri








dent tests. This conclusion has led researchers to propose extensions [48] to Fisher’s
method to include weights for the tests.
Each combined p-value method has its own advantages and drawbacks. For
instance, Fisher’s method suffers from a significant drawback in an asymmetric sen-
sitivity to small p-values compared to large p-values [162]. Other methods may have
this drawback as well. To handle this issue, we considered approaches to minimize the
influence of outliers. These approaches include (1) trimming p-values using a quan-
tile approach, and (2) capping individual p-values with a minimum p-value threshold.
Preliminary results suggest that only considering a median percentile provides marked
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900 bp 1800 bp 450 bp 450 bp
R1    R2    R3     R4    R5    R6    R7    R8    R9   R10  R11  R12  R13  R14  R15  R16                                                            R59  R60
Initial Segment
Compute the standard 
deviation (SD) for the initial 
segment 
segment = initial_segment;
SD = SD of initial_segment 
For  i= R11 to Island_length (R60)
{  
   If ((R11>(2*SD)) && (segment_size >=10))
   {       
      make a new segment from R1-R10;
  segment = {R11};
   }
   else 
   {
segment = segment + R11;
SD = SD of segment;
   }
}
If Island_length > 1000 bp
Segment further 
Figure 7.5: Further island segmentation example (w = 30 bp).












































Before Segmentation After Segmentation
Figure 7.6: The performance of further island segmentation algorithm.
improvements in reducing the false discovery rate (Figure 7.7) with a slight reduc-
tion in detecting true positives for the Fisher’s method. In contrast, thresholding





























































































Before Trimming After Trimming
Figure 7.7: Improvement of detecting the true non-DE for Fisher’s method using
median percentile approach.
One of the key assumptions with the combined p-value methods investigated
in this study is that the p-values for a given sample (in this case, a gene) are inde-
pendent. However, since an individual gene is composed of several islands and their
expression (partially at the exon level) are likely to be correlated, at least in terms
of the biological results, their p-values are not strictly independent. Thus, methods
that can combine dependent p-values, such as Brown’s [15] and Kost’s [77] methods,
may yield more consistent results.
All of the combined p-value methods considered in this study provide a number
of false positive results (not shown). One potential reason for non-trivial false positive
rates is that the datasets used in this study look at DE at a whole transcript level.
However, by breaking up the transcripts into additional islands, it is possible to detect
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alternative splicing events, which are likely to make up a significant amount of the
false positive data. However, neither the MAQC project nor Marioni’s Liver and
Kidney dataset provide any validation of alternative isoforms, and therefore, this was
excluded from additional interrogation.
Although the main aim of this dissertation is to develop an RNA-Seq differen-
tial expression analysis method that provides a solution for the limitations associated
with the current methods, there are still other factors (we refer to them here as bioin-
formatics challenges) which may effect the results regardless of which DE method
is used. Thus, despite the advantages NGS technologies have brought to the -omics
community, particularly in the transcriptomic realm, a number of new challenges
have been introduced as well. Below, we list some of the challenges that have been
introduced to the RNA-Seq community (there may be other challenges in other areas
but since the focus of this dissertation work is limited to RNA-Seq, we focus only on
the challenges in this area).
1. Mapping Uncertainty: considering short read sequences, some reads will
map equally well to multiple locations on the reference genome which may effect
the analysis results. As an example, non-unique regions within genes (such as
domains or conserved family features) may show up as arbitrary under or over
represented due to mapping.
2. Transcriptome Reconstruction: as many eukaryotic genes can produce dif-
ferent transcripts that encode for different isoforms and considering the reads
are short, it is hard to determine which reads originate from which isoforms.
In addition, low expressed genes (genes represented by a few reads) will be, in
most cases, discarded and their transcripts will not be assembled. Furthermore,
identifying mature transcripts is a difficult task since some reads originate solely
from exons [44].
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3. Sequencing Depth: to detect and measure RNA-Seq transcripts, one needs
to decide on the sequencing depth. This is an issue of coverage versus cost.
To provide better expression estimate, more coverage, which requires more se-
quencing depth, is needed but this will result in more cost. Sequencing depth is
very important factor that needs more attention since additional reads results in
the identification of low-abundance regions or transcripts, and provides a more
accurate picture of the actual dynamic range of expressed transcripts.
7.3 Computational and Space Complexity
To measure the efficiency and feasibility of any computer algorithm, the com-
putational complexity in terms of time (the amount of time required to run the
algorithm) and space (the amount of memory required to run the algorithm) has to
be measured and estimated. This is critical in considering scalability, particularly
with the likelihood that the input size is large as the case with the next-generation
sequencing data IBSeq uses. Generally, a complexity analysis is based on counting
primitive operations an algorithm needs to perform. Thus, the number of steps IBSeq
takes as a function of the input size needs to be measured and assessed in terms of
its efficiency by measuring the upper bound amount of time and space required to
execute the algorithm. Please refer to Algorithm 1 and Figure 5.2 throughout this
discussion as they represent the IBSeq steps discussed here.
Let us first define the notations involved in this analysis as follows:
N : number of samples (range from 2-10).
M : number of replicates (range from 3-5).
Rnm: reads per file (range from 30-80 million).
Inm: number of pre-islands in sample n, replicate m.
G: genome size (∼ 3 billion base pairs).
L: read length (range from 35-100).
W : window size (range from 30-50bp).
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For most RNA-Seq studies, there will be a number of N samples where each
sample may have M replicates, R reads, and a genome of length G as an input. Note
that in most cases, the genome size is constant, on the order of 3 billion base pairs
(bp). While the sample size R and the genome length G may not be constants, for
most RNA-Seq projects, R will range from 30-80 million reads, while G is typically
around 3 billion base pairs (bp). Thus, in the worst case scenario (the upper bound
on algorithm performance), the mapping process will run in NM × (LR+ LG) time
depending on the number of reads R and therefore the upper bound time complexity
of this step is on the order of NM × L(R + G) or O(NM × L(R + G)). Given
that M ≈ N and L is a constant which can be discarded, the time complexity is
roughly O(N2(RG)). In addition, the genome length G can be discarded since it is
a constant in most cases as discussed above. Therefore, the time complexity of the
mapping process function is O(RN2). As for the space complexity, this step will be
roughly based on the genome size G. Although the mapping step is not part of IBSeq,
the computational and space complexity of this step is discussed here since it is an
essential process of any RNA-Seq analysis and it is assumed to be performed before
using IBSeq. Refer to [139] for a more in-depth discussion about mapping complexity.
The per base count step (step 1 of IBSeq) will run in (NM×G) time depending
only upon the genome size G. Similar to mapping, given that M ≈ N and G is a
constant, the time complexity of this step can be O(N2) (approximately quadratic
time). Similarly, the region construction process (step 2) will run in (NM × G/W )
time. Considering G and W are constants and can therefore be discarded and M ≈ N ,
the time complexity of this step is on the order of N2 or O(N2). The space complexity
of the two steps clearly depends on the genome size G. The island construction
process (step 3) will be treated the same as region construction step and will run in
(NM × G/W ) times. Given the constants G and W , the time complexity of island
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construction is also a quadratic on the order of N2 or O(N2).
In the second part of the IBSeq algorithm where all possible pairwise compar-
isons between the samples are performed to test for island differential expression (step

















NM is much smaller than
1
2
(NM)2 and has no
significant effect on the running time, this term can be discarded. In addition, we can
also discard the constant
1
2
since it takes a constant amount of time and insignificant
for the growth function. Therefore, the time complexity of this part in the worst case
scenario is on the order of I×(NM)2 or O(I(NM)2) which is a quadratic complexity.
This is clearly the larger than the time complexity of all other previous steps.
The last step which combines the significance of DE islands corresponding to
each feature (step 5) will run in the same time as step 4 with an order of O(I(NM)2)
with an additional parameter Csig which represents the complexity of the combined
p-value method used. Thus, the time complexity in this context will be O(I(NM)2×
Csig) where Csig represents steps in the combined p-value method used. Similar to the
previous steps, the space complexity of step 4 and 5 will be in most cases dependent
on the genome size.
Overall, the time complexity of IBSeq algorithm can be written as a total of











+O(I(NM)2)× Csig︸ ︷︷ ︸
Step 5
preprocessing : mapping read sequences to the reference genome.
Step 1 : compute per-base count.
Step 2 : region construction.
Step 3 : island construction.
Step 4 : island differential expression.
Step 5 : combining the significance of islands.
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It is obvious that the time complexity of IBSeq is a summation of quadratic
complexities which shows a potential room for improvement. However, it can be
acceptable and feasible in our case because of two reasons: (1) most RNA-Seq studies
use a small number of samples N (due to sequencing cost), (2) since the number of
samples is a small (range from 2-10), the growth rate of the complexity will not grow
fast where it will start increasing only with larger values of N (e.g. N > 50). The
space complexity for almost all IBSeq steps will roughly be based upon the genome
size.
The complexity analysis discussed above is an asymptotic upper bound estima-
tion of IBSeq efficiency and does not indicate the actual performance of the algorithm.
In order to perform an actual measurement, IBSeq needs to be run using real data
and the amount of both CPU time and memory space required to perform each step
has to be recorded. Therefore, we performed an actual assessment of the IBSeq re-
quirements of time and space using four RNA-Seq datasets described in Table 7.1.
Table 7.1: Description of the datasets used in the complexity analysis.
Dataset # of Samples Read Length Total Reads Organism
MAQC2 [16] 2 35bp
hbr: 81,250,500
Humanuhr: 92,524,365
MAQC2 [113] 2 50bp
hbr: 53,238,798
Humanuhr: 59,561,348
Marioni’s data [100] 2 36bp
Liver: 69,618,202
HumanKidney: 66,404,506
Petruska’s data [59] 3 59bp
T0: 63,623,836 x 2
RatT7: 48,485,234 x 2
T14: 41,050,145 x 2
IBSeq was implemented using Perl version v5.14.2 and run on a Dell Alien-
ware Area-51 Gaming workstation with Intel(R) Core(TM) i7 CPU 930 @ 2.80GHz
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(8 CPUs/4 cores) and 12 GB RAM. The CPU time and memory usage were recored
for each step. Table 7.2 shows the amount of time and space usage for each step of
the IBSeq algorithm while Figure 7.8 represents the corresponding charts.
Table 7.2: The amount of time and space recorded for each step in IBSeq using four
RNA-Seq datasets (D=Dataset).
Process
CPU Time (Minutes) Memory (Kilobytes)
D1 D2 D3 D4 D1 D2 D3 D4
Mapping 27 55 24 34.5 3613000 3369000 3530000 2664000
Per-base count 154 168 154 153 1902000 1902000 1902000 2045000
Region construction 99 101 99 92 7520 7516 7524 7524
Island construction 18 17 15 18 1453000 1452000 1455000 1357000
Island DE 82 56 138 52 3095000 3095000 3095000 3342000


























































































Figure 7.8: The amount of time and space utilized by each step in IBSeq using four
RNA-Seq datasets.
By looking at the charts above, it is clear that the island construction step
took the lowest running time which was expected since this step does not require
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intensive computations. In terms of memory utilization, the performance of this step
utilized only a small fraction of the memory (12%). Although the mapping step took
the second lowest running time, it utilized the largest space of memory ranging from
22%-30%. This was expected since this process needs to load the indexed reference
genome, which is usually in GBs, into the memory. In terms of the best process that
took the smallest memory space, the region construction step along with combining
the significance utilized the smallest space with only 0.1%. However, combining the
significance along with per base count step took the largest running time. Although
the running time for island DE process was small, it utilized the largest memory
space along with the mapping with 25% of the physical memory. In conclusion, it
is observed that the per base count and combining the significance processes require
the largest running time. This result is expected since the per base count is based on
the length of reference genome which is in most cases in the range of 3 billion bases.
Similarly, the computation of combining the significance of genetic features is based
on the number of annotated features which is usually large (ranging from 18000-
80000). In contrast, mapping and island DE processes require the largest memory
space. This observation is to be expected since the mapping process requires the
large reference genome index to be loaded into the memory. Similarly fo island DE,
in order to perform the DE test, we need to load the large region files into the memory
to extract all island counts. Therefore, these processes that take the largest running
time and largest memory space are considered for further optimization in order to
minimize the requirement of both time and space.
7.4 Future Directions
There are several exciting directions for future research inspired by this disser-
tation. In this chapter, we summarize briefly some of the potential research directions.
139
7.4.1 Potential IBSeq Extensions
Since IBSeq is in its initial version, a number of potential extensions need to
be implemented in the near future to improve the efficiency and robustness including:
1. Alternative splicing detection: currently, IBSeq does not support the detection
of alternative splicing events. Since most genes composed of multiple exons
in eukaryotic have multiple isoforms, alternative splice detection is important
in order to understand subtle differences tha occur at a transcript level. As
an initial approach to detect alternative splicing events, transcripts could be
broken up into additional islands which are then stitched together to check for
expression differences between isoforms within the same gene.
2. Biological variation: IBSeq as for now is capable of detecting island differential
expression using technical replicates only. We plan in the future to adapt the
current statistical model in order to accommodate for the biological variation
of genetic features across biological replicates (IBSeq bio).
3. Visualization: the current form of IBSeq results is a tab-delimited file containing
all statistical and expression information which can be visualized on one of the
genome visualization tools such as UCSC genome browser, Integrative Genomics
Viewer (IGV), or GBrowse. In the future, we plan to develop a visualization
package adapted specifically for IBSeq results.
7.4.2 Combining the Significance of Islands
As discussed in Section 6.4, one of the major assumptions with the combined
p-value methods studied is that the p-values for a given sample (in this case a gene)
are independent. But since an individual gene is composed of several islands, there
is a strong likelihood of correlation between expression of islands and therefore their
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p-values are not strictly independent. In the future, we plan to consider methods that
can combine dependent p-values such as Brown’s [15] and Kost’s [77] which may yield
more consistent results. In addition, we also plan to continue exploring additional
weighted measures in order to provide realistic p-value combinations. Furthermore,
We hope to continue further analysis to look at the effects of each of the combined
p-value methods on alternative splice detection in the future.
7.4.3 Comparison to Transcriptome Assemblers
The main focus of this research was to extend the knowledge of differentially
expressed regions outside of known annotations. While this may be a fruitful ap-
proach for de novo transcriptome discovery, we have yet to compare it to de novo
transcriptome assemblers such as Trans-Abyss [130], Oases [137], or Trinity [49]. This
is due to the fact that our IBSeq approach as currently constructed is a mapping-
based methodology in contrast to these assembly-based methods. In the future, we
will consider an IBSeq-based methodology to de novo transcript assembly.
7.4.4 IBSeq Optimization
Since IBSeq consists of several steps, the amount of time and space required
to execute each step varies from one to another. For instance, the computation of per
base count step is very expensive in terms of both time and space since it needs to
compute the number of reads mapping to each position in the genome. To achieve a
drastic improvement in speed and reduce the running time of IBSeq algorithm, we plan
to implement a new version of IBSeq that can be run on one of the massively parallel
computing platforms such as the graphics processing unit (GPU) which provides
massively parallel computational power that assures the speed of algorithms. This
can be performed using CUDA (Compute Unified Device Architecture) C/C++ to
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program GPUs. Since the various steps of IBSeq are performed for each sample, steps
can run in parallel which is expected to speed up the algorithm in large magnitude.
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ABySS Assembly By Short Sequences
auROC Area under Receiver Operating Characteristic
BFAST Blat-like Fast Accurate Search Tool
BLAST Basic Local Alignment Search Tool
BLAT the BLAST-Like Alignment Tool
DAG Directed Acyclic Graph
DDBJ DNA Data Bank of Japan
DE Differential Expression
ELAND Efficient Large-Scale Alignment of Nucleotide Databases
EMBL European Molecular Biology Laboratory
emPCR Emulsion Polymerase Chain Reaction
ERANGE Enhanced Read Analysis of Gene Expression
GTF Gene Transfer Format
LRT Likelihood Ratio Test
MAQ Mapping and Assembly with Quality
MISO Mixture of Isoform
mRNA Messenger RNA
NGS Next Generation Sequencing
PCR Polymerase Chain Reaction
PGM Personal Genome Machine
ROC Receiver Operating Characteristic
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SRA Sequence Read Archive
SSAKE The Short Sequence Assembly by K-mer Search and 3’ Read Extension
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